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Sexually transmitted disease (STD) testing among sexually active young women is 
essential in preventing and controlling the STD epidemic.  STD testing is critical because 
infections such as Chlamydia trachomatis and Neisseria gonorrhoeae are primarily asymptomatic 
in women.  If women do not routinely test for STDs, this can facilitate the spread of these 
diseases and lead to serious sequelae. 
 The research presented explores socio-demographic, psychosocial, and health-related 
factors that may be associated with young women’s STD testing behaviors.  The Health Belief 
Model (HBM) provides the theoretical framework for explaining the relationships that exist 
between background factors, HBM perceptions of STDs and STD testing, and the total number 
of STD tests completed during the two-year study. 
 The population studied for this research is a sample of 14 –29 year old women, 
approximately 80% of whom are African-American.  Univariate regression analysis between 
background factors and the outcome indicated that age, race, education, having symptoms of an 
STD at baseline, current antibiotic use, and having condom problems were associated with an 
increasing number of STD tests completed.  A similar analysis between HBM perception 
variables and the outcome showed that only perceived severity was significant.  A multivariate 
stepwise linear regression model of significant background and perception factors revealed that 
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having symptoms at baseline, current antibiotic use, and having condom problems were 
significant to an increasing number of total STD tests completed.  
These findings demonstrate that an assessment of behaviors and current health status of 
young women can be helpful in understanding utilization of STD services.  The results also 
suggest that the HBM may not be sufficient in characterizing STD testing behaviors, however, 
improved measures of these constructs can better assess trends in the data. The public health 
significance of this study is that it provides theoretical and empirical attention to factors 
associated with STD testing behaviors, an area of research that has received limited 
consideration. 
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1. CHAPTER I. 
1.1. INTRODUCTION 
 
1.1.1. Statement of the Problem 
There are more than 65 million people currently living in the United States with an 
incurable sexually transmitted disease (STD) (CDC, 2001).  In addition, there are approximately 
fifteen million new cases of STDs every year (KFF, 2003).  Of these new cases, approximately 
two-thirds occur among people under the age of 25 (KFF, 2003). Chlamydia trachomatis 
(Chlamydia) and Neisseria gonorrhoeae (Gonorrhea) are curable STDs which are the first and 
second most commonly reported notifiable diseases, respectively, in the US (CDC, 2003). 
Although STDs remain widespread, they are still considered to be “hidden” epidemics with 
tremendous health and economic consequences (IOM, 1997). 
 The Institute of Medicine (IOM) characterizes STDs in this manner because STDs remain 
an unspoken phenomenon in public even though they infect all segments of the US population 
(IOM, 1997).  Another reason STDs can be described as hidden may be due to the asymptomatic 
nature for some of the diseases.  Lack of awareness by the general public concerning the risks 
associated with STDs may cause serious health problems years after infection (IOM, 1997). 
Additionally, STDs not only lead to long-term health consequences, but they also add billions of 
dollars to the nation’s healthcare costs each year – an estimated $17 billion annually (CDC, 
2001; Shafii & Burstein, 2004).    
 Adolescents and young adults are also at high risk for acquiring an STD (IOM, 1997).  
According to the CDC, 42 percent of 20 to 24-year-olds and 25 percent of 15 to 19-year-olds 
account for all newly-reported cases of STDs in the US (KFF, 2003).  Factors that have an effect 
on risk-taking behaviors among adolescents include beliefs of invulnerability and an immature 
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approach to decision-making (Shafii & Burstein, 2004).  In addition, social factors such as 
poverty, limited STD health care services, older male partners for female adolescents, sexual 
abuse and violence, and adverse  adolescent health-seeking behaviors have been identified as 
contributing to adolescents’ increased susceptibility to STDs (Shafii & Burstein, 2004). 
  Research also suggests that young women, especially African-American women, suffer 
disproportionately from STDs.  Young women are biologically more susceptible to infection 
because the cells on their cervix are particularly susceptible to STDs such as Chlamydia and 
gonorrhea (CDC, 2001; HP, 1999).  In addition, the rate of Chlamydia in African-American 
females in the US was eight times higher than in white females (1,638.3 and 202.5 per 100,000, 
respectively) (CDC, 2001).  Differences in STD prevalence have been attributed to the over-
representation of specific racial and ethnic groups receiving care for STDs in the public sector 
compared to private sources (Shafii & Burstein, 2004).  However, the disproportionate impact of 
STDs among young women and African-American females, reflects the need for improved 
health outcomes among young women.  
Fortunately, Healthy People 2010 has identified the promotion of responsible sexual 
behaviors, the strengthening of community capacity, and increasing access to quality services to 
prevent STDs and their complications, as an overall objective for reproductive health  (HP, 
1999). A major complication of Chlamydia trachomatis and Neisseria gonorrhoeae infections is 
a clinical syndrome named pelvic inflammatory disease (PID).  The sequelae of PID can lead to 
tubal scarring which may result in pelvic pain, infertility, ectopic pregnancy, or even death (Suss, 
Homel, Hammerschlag, & Bromberg, 2000). Cervical infections which cause PID are also risk 
factors for HIV transmission (Suss et al., 2000).  Thus, diagnosis and proper treatment of 
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chlamydial and gonococcal infections are essential for improving the reproductive health of our 
nation. 
However, proper diagnosis and treatment of chlamydial and gonorrheal infections in 
women can only occur if a provider screens them for STDs or if they seek STD testing.  Due to 
the asymptomatic nature of STDs and other patient or provider factors that may impact STD 
testing, this may be difficult.  So, in an attempt to decrease the prevalence of Chlamydia and 
gonorrhea among women in the US, universal screening recommendations have been made.  
Research has shown that screening women for Chlamydia trachomatis can reduce the incidence 
of PID by more than 50% in the course of one year (Scholes et al., 1996).  The Scholes study and 
others may have influenced the CDC in 2001 to recommend that sexually-active women under 
the age of 25 be screened for Chlamydia every six months (USPSTF, 2001).  Hence, routine 
testing of sexually-active women is the most effective way to identify and treat women with 
Chlamydia (ASHA, 2001). In addition, it is equally important to encourage young women to 
actively seek STD testing if sexually active.  
Issues related to STD testing and screening continue to be critical factors in controlling 
the STD epidemic.  Research that assesses utilization of services for the prevention and treatment 
of STDs has been noted as a major area of scientific and practical relevance for the prevention 
and control of STDs (Amaro & Gornemann, 1991).  Experts have suggested that understanding 
patient and provider characteristics as well as psychosocial and environmental factors which may 
affect STD-healthcare seeking behaviors is an essential tool for reducing sequelae of STDs.  
Therefore, this exploratory study has been undertaken in order to examine predictors of 
Chlamydia and gonorrhea screening behaviors among a high-risk group of young women. 
 
 13
1.1.2. Research Questions 
 The objective of this study is to examine socio-demographic, psychosocial, and health-
related predictors of STD testing among high-risk young women.  The research questions 
address the predictors’ influence on the outcome variable: total number of STD tests completed 
during two years of the DAISY (Detection Acceptability Intervention for STDs in Young 
women) study – a home STD screening intervention study.  The following research questions are 
addressed: 
1. What socio-demographic, psychosocial, and health-related [background] variables are 
associated with the 4 perceptions of STDs (perceived risk, severity, benefits, and 
barriers)? 
2. Are the perceived susceptibility and severity of STDs, the perceived benefits of STD 
testing, and the perceived barriers to STD testing [perceptions] associated with the 
number of total STD tests completed?  
3.    Overall, what background factors and perceptions are associated with the number of 
total STD tests completed? 
These questions have been developed using a modified framework of the Health Belief Model 
(HBM).  This model will be discussed later in Chapter Four. 
1.1.3. Significance of the Study 
 The CDC provides clinical prevention guidelines and bases the prevention and control of 
STDs on the following strategy: 1) education and counseling of persons at risk on ways to take 
part in safer sexual behavior; 2) identification of asymptomatically infected persons and of 
symptomatic persons unlikely to seek diagnostic and treatment services; 3) effective diagnosis 
and treatment of infected persons; 4) evaluation, treatment, and counseling of sex partners of 
 14
persons who are infected with an STD; and 5) pre-exposure vaccination of persons at risk for 
vaccine-preventable STDs (MMWR, 2002).  This research focuses on the second and third 
strategies.  Exploring the predictors of STD testing behaviors can improve access to quality STD 
services and identify and treat those who are asymptomatic or at increased risk for STDs. 
In an effort to increase and improve access to quality services which prevent STDs and 
their complications, understanding what factors influence individuals to seek or not seek 
treatment is essential for effective control of STDs (Amaro & Gornemann, 1991).  These factors 
can affect how STD prevention services are provided to specific populations. Additionally, these 
factors can assist health professionals with detecting and treating individuals who are either 
asymptomatic or not likely to seek diagnostic and treatment services. The current study has 
utilized a larger study, the DAISY study, whose aims are to: 1) evaluate the effectiveness of 
home sampling to increase adherence to routine STD screening (i.e. every 6 months); and, 2) 
compare the number of lower genital tract Chlamydia infections detected in a home screening 
and return visit group (recruited from clinic and community populations) in order to determine 
STD perceptions and socio-demographic, psychosocial, and health-related characteristics of 
young females in Pittsburgh, PA who are seeking STD healthcare.  Thus, a better understanding 
of factors which influence health-seeking behaviors can ultimately be used to improve access to 
quality STD services. 
 The use of a theoretical model to investigate the relationships between predictor and STD 
outcome variables is essential in explaining the determinants of STD healthcare seeking 
behavior. This exploratory study is important because it fills some of the research gaps in this 
subject area. In addition, it may well be the first use of the majority of HBM components to 
explain STD health-care seeking behaviors among young women.  Although individual HBM 
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constructs (i.e. perceived risk and perceived susceptibility) have been used to characterize certain 
STD-protective behaviors such as condom use, there is limited literature on how most of the 
HBM components affect STD testing behaviors.  Hence, this study will significantly add to the 
literature and supply evidence for further exploration of HBM constructs as an explanatory 
framework for examining this area of public health significance.  
 In summary, the current study has several significant aspects.  It adds to the theoretical 
understanding of how HBM constructs can be used to investigate STD testing behaviors among 
high-risk young women.  Second, this study investigates whether differences in STD testing 
behaviors exist between clinic and community populations (i.e. healthcare users vs. non-
healthcare users) and between racial groups.  Furthermore, there are a number of practical 
aspects to this study.  First, research which sheds light on an understanding of patient 
characteristics regarding utilization of STD services is urgently needed.  Understanding 
perceptions of susceptibility held by certain populations, their perceived barriers to care, and 
how norms and/or stigma affect STD testing behaviors is essential to improving STD services to 
young women.  Second, health care providers and public health professionals need to be 
knowledgeable about the provision of treatment services and provider characteristics which may 
impede or enhance one’s willingness to seek STD testing.  Third, in order to improve the 
detection and treatment of Chlamydia and gonorrhea for prevention of PID and understanding 
factors related to usage of innovative testing strategies such as home sampling, will be beneficial 
in reducing the incidence and re-infection of persons with these diseases.  Fourth, there are racial 
disparities that exist in the STD epidemic.  This study will attempt to characterize trends in the 
data that may demonstrate differences in background and risk perceptions which affect STD 
testing behaviors.  Lastly, this study can provide the platform for improving STD prevention 
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interventions (i.e. developing STD knowledge and counseling sessions with home sampling 
techniques, improving services to treat partners for these diseases, etc.) that focus on preventing 
PID among high-risk young women.   
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2. CHAPTER II.  
2.1. REVIEW OF THE LITERATURE 
 
 The primary objective of this study is to examine socio-demographic, psychosocial, and 
health-related predictors of STD testing behaviors among a high-risk group of young women.  
Previous studies examining the association of factors with STD healthcare-seeking behavior 
have found that stigma (Fortenberry et al., 2002), inaccurate perceptions of risk (Banikarim, 
Chacko, Wiemann, & Smith, 2003), and past STD history (DiClemente et al., 2002) have an 
affect on this behavior.  Although these studies provide some understanding of factors that affect 
utilization of STD services, it is imperative that more attention be placed on researching patient 
characteristics that impact STD testing behaviors.  This information can prove to be beneficial in 
enhancing STD detection and treatment programs and more effectively reduce the incidence of 
PID.  Additionally, racial disparities in STD rates among women and African-Americans, 
warrant the need to examine trends in data that may explain why inequities in STD acquisition 
exist. 
 This chapter presents a discussion of a) background on Chlamydia and gonorrhea 
screening/testing and treatment guidelines, b) previous studies conducted that investigate issues 
related to STD healthcare-seeking, and c) background information related to an understanding of 
racial disparities in STD rates. 
2.1.1. Background on Chlamydia and Gonorrhea  Screening & Treatment 
Transmission 
 Chlamydia is a curable sexually transmitted infection (STI) which is caused by the 
bacteria Chlamydia trachomatis (NIAID, 2004).  Chlamydia is primarily transmitted during oral, 
vaginal, or anal sexual contact with an infected partner (NIAID, 2004).  The site of initial 
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infection for Chlamydia is most often the cervix, yet, the urethra and rectum may also be infected 
(MMWR, 1993). 
 Gonorrhea is also a curable STI caused by a bacterium called Neisseria gonorrhoeae 
(NIAID, 2002).  Gonorrhea is known to infect the genital tract, the mouth, and the rectum 
(NIAID, 2002). For women, gonorrhea first infects the cervix and can later spread to the uterus 
and fallopian tubes resulting in PID, if untreated (NIAID, 2002). 
 In men, the sequelae of chlamydial and gonorrheal infections are rare.  Sequelae that may 
occur in men is called epidydimitis, but the incidence of this condition is much lower than the 
incidence of PID in women (Burstein & Murray, 2003). 
Clinical Manifestations 
 Genital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae closely 
parallel one another in terms of clinical manifestations (Stamm, 1999).  Both organisms usually 
infect columnar or transitional epithelium of the urethra and extend to the endometrium, salpinx, 
peritoneum, and the rectum.  These infections lead to subepithelial inflammation, epithelial 
ulceration, and scarring.  In rare cases, both organisms produce systemic manifestations (Stamm, 
1999). 
Most early symptoms of Chlamydia and gonorrhea are considered to be mild.  Due to 
these mild symptoms, many women are unaware that they are infected.  For Chlamydia, 
symptoms may appear within 1 to 3 weeks after being infected.  These symptoms include 
abnormal discharge from the vagina or penis or pain when urinating (NIAID, 2004). 
For gonorrhea, symptoms generally appear within 2 to 10 days after sexual contact with 
an infected partner (NIAID, 2002).  In women, initial symptoms may include: bleeding 
associated with vaginal intercourse, painful or burning sensations when urinating, or vaginal 
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discharge that is yellow or bloody.  Advanced stages of gonorrhea can produce symptoms such 
as pain, bleeding between periods, vomiting, or fever which may indicate the development of 
PID (NIAID, 2002). 
Diagnosis and Treatment 
 Nucleic acid amplification tests (NAATs) are the newest diagnostic tests in the detection 
of Chlamydia trachomatis and Neisseria gonorrhoeae infections (Burstein & Murray, 2003).  
NAATs are highly sensitive and are specific tests for these infections.  There are four tests that 
are licensed for both Chlamydia and gonorrhea testing and some require only a single specimen 
for both tests (Burstein & Murray, 2003).  Overall, there are five NAATs and they are 
polymerase chain reaction, ligase chain reaction (no longer available in 2004-2005), strand-
displacement amplification, hybrid capture II system, and transcription-mediated amplification.  
The first four tests, respectively, are the combination tests used to detect both chlamydial and 
gonorrheal infections (Burstein & Murray, 2003). Most specimens collected for these tests are 
from cervical swabs, urethral swabs, or first-void urine, however, hybrid capture II system only 
takes cervical specimens. 
 NAATs offer many advantages over older methods of diagnosing these infections.  The 
tests are extremely sensitive, have the ability to test urine specimens, and provide the opportunity 
to test asymptomatic females without an invasive genital examination. For symptomatic patients, 
a full genital examination is needed to evaluate for PID and other infections that may cause 
vaginal and urethral discharge (Burstein & Murray, 2003).  Therefore, NAATs offer an 
opportunity to provide a less invasive testing procedure that is highly effective in detecting 
chlamydial and gonorrheal infections. 
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 Older tests utilized for specifically diagnosing Chlamydia trachomatis are cultures, 
enzyme immunoassay (EIA), and DNA probes.  These tests are less sensitive and require 
cervical or urethral specimens (Burstein & Murray, 2003).  Older tests for detecting Neisseria 
gonorrhoeae are cultures, DNA probes, and gram stains.  As mentioned earlier for Chlamydia 
tests, these laboratory tests for gonorrhea are less sensitive and require an invasive genital exam 
(Burstein & Murray, 2003). 
 Single dose therapies to treat (not cure) uncomplicated chlamydial and gonorrheal 
infections are available and they include a class of antibiotics called fluoroquinolones (i.e. 
ciprofloxacin, ceftriaxone, ofloxacin, and levofloxacin) (Burstein & Murray, 2003). In 2002, the 
CDC recommended that positive gonorrhea tests among adolescents should be treated for both 
chlamydial and gonorrheal infections, unless a negative result was obtained for a sensitive 
Chlamydia test (co-infections often occur among adolescents) (Burstein & Murray, 2003).  
Single dose azithromycin and doxycycline can also be used to treat Chlamydia trachomatis.  
Neisseria gonorrhoeae infections have had resistance to penicillin and tetracycline classes of 
antibiotics and a single 1-g azithromycin dose has resulted in suboptimal cure rates for gonorrhea 
(Burstein & Murray, 2003).  Moreover, fluoroquinolones are not recommended for persons 
younger than 18 years of age because they have caused articular cartilage damage in juvenile 
animal models (Burstein & Murray, 2003).  In addition, quinolones are not recommended as 
treatment for gonorrheal infections in Asia, the Pacific, California, or Hawaii because of reported 
resistance in these areas (Burstein & Murray, 2003).  However, a single injection of ceftriaxone 
can cure gonorrhea. 
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Screening Recommendations 
 Due to the high frequency of asymptomatic chlamydial and gonorrheal infections and 
their potentially harmful sequelae, screening programs have been created to detect and treat 
infected women early.  Accordingly, universal and selective screening strategies have been 
recommended by several health service agencies.  In 1993, the CDC offered universal screening 
recommendations that all sexually experienced females be screened for Chlamydia trachomatis 
(Fiscus, Ford, & Miller, 2004).  The American Academy of Pediatrics, the US Preventive 
Services Task Force (USPSTF), and the American Medical Association (AMA) have also made 
similar recommendations.  Moreover, between 1997 and 2000, these agencies expanded their 
guidelines to screen all sexually active women younger than age 25 for Chlamydia (Chacko, 
Wiemann, & Smith, 2004; Huppert & Hillard, 2003).  In addition to screening recommendations, 
annual chlamydial screening among sexually-experienced female adolescents is now a quality of 
care measure in the Health Plan Employer Data and Information Set (HEDIS) which can be used 
to evaluate screening practices (Fiscus et al., 2004). 
 Selective screening strategies are alternative methods to universal screening that usually 
incorporate risk assessments as part of their approach to identifying infected females. These 
strategies include setting screening criteria based on demographic and behavioral markers, 
symptoms, and signs (W. Miller et al., 2000). Some of the common risk markers for these 
criteria are age, number of sexual partners, and physical exam findings such as cervicitis (W. 
Miller et al., 2000).  Selective screening strategies have been widely utilized because universal 
screening may be too expensive in some settings (W. Miller et al., 2000).  Studies of these 
screening strategies are useful in determining the most effective approach for selecting screening 
criteria. 
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 Universal and selective screening studies have been beneficial in determining risk factors 
to use as criteria, recognizing disparities in screening programs and evaluating the effectiveness 
of screening strategies. An intervention trial conducted by Scholes and researchers (1996) found 
that at-risk women who were randomized to a screening group versus a usual care group had a 
56 percent lower incidence of pelvic inflammatory disease.  This population consisted of over 
2,600 single women, primarily between the ages of 18 and 24, who were mostly non-Hispanic 
white (69%) and African-American (21%).  The selection of those at-risk for Chlamydia 
infection were based on a risk score that included age less than or equal to 24, black race, 
nulligravidity (having no prior pregnancies), douching in the preceding 12 months, and two or 
more sexual partners in the preceding 12 months. Those in the intervention group were contacted 
to be tested for Chlamydia while the usual care group were not contacted by the study team for 
follow-up evaluation (Scholes et al., 1996). Hence, selective screening strategies are useful in 
detecting Chlamydia infections and may ultimately decrease the incidence of PID among at-risk 
women. 
 Selective screening strategies can be difficult to establish because they may be based 
upon many factors such as the demographics of the population the clinic serves, risk factors 
among clients, and financial resources.  A clinic-based study that evaluated the diagnostic 
performance of different screening criteria (age alone, 1993 CDC recommendations, and 
different recommendations from 4 areas – Seattle, Wisconsin, Ontario, and California) concluded 
that age alone is a reasonable strategy when site-specific criteria cannot be developed either due 
to financial or clinic constraints (W. Miller et al., 2000).    Another study performed by Marrazzo 
and colleagues (1997) compared three sets of Chlamydia screening recommendations (CDC, 
Region X Chlamydia project, and age alone). They found that age alone (younger than 25) 
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performed best even in this low-risk population where only 59 to 71 percent of women had to be 
screened with sensitivity of detecting Chlamydia at 92 to 94 percent (Marrazzo, Fine, Celum, 
DeLisle, & Handsfield, 1997).  In conclusion, selective screening criteria can be helpful in 
reducing the proportion of women screened and increasing the number of women diagnosed and 
treated with chlamydial and gonorrheal infections. 
 Although selective screening strategies exist there still appears to be a disparity in 
screening at-risk women for STDs.  An examination of the 1988 National Survey of Family 
Growth revealed that black race and individuals attending family planning clinics were more 
likely to be tested for STDs, independent of their individual characteristics (Mosher & Aral, 
1991).  However, among groups with high-risk behaviors in this study, only 34 percent of 
sexually active teenagers and 43 percent of women with an STD history were screened  (Mosher 
& Aral, 1991).  Another study conducted by Ellen, Lane, and McCright (2000) also found that of 
118 sexually active African-American adolescents in a low-income neighborhood of San 
Francisco, only 48 had been screened within the past 12 months for STDs.  A low rate of 
screening was even found among those who had a primary care visit since after their first sexual 
encounter (Ellen, Lane, & McCright, 2000).   Thus, this study demonstrates that family planning 
clinics may serve as good providers of STD screening services and that screening practices for 
sexually active individuals are low overall.  Additionally, improved targeting strategies should 
not only include race but be inclusive of females who have high-risk behaviors or a past STD 
history. 
 A similar study conducted more recently by Fiscus, Ford, and W.C. Miller (2004) 
examined Wave 1 of the National Longitudinal Study of Adolescent Health (Add Health). This 
study reported on factors related to receipt of STD testing and treatment as well as the types of 
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clinical sites that are commonly used for delivery of care.  Results showed that only one in five 
sexually experienced, adolescent females (grades 7-12, approximately 29% Black and 50% 
White) in the US are receiving recommended STD screening (Fiscus et al., 2004).  Although 66 
percent of sexually experienced females reported routine physical examinations, only 22 percent 
said that received STD testing or treatment and approximately 44 percent had gotten their care 
from a community health center (Fiscus et al., 2004).  In addition, the strongest predictors of 
screening were older age, being Black, having Medicaid/Medicare, and having had a physical 
exam in the past year (Fiscus et al., 2004).  As a result, these findings suggest that females may 
be unaware of STD testing that may occur at a routine exam. In addition, there needs to be 
improved adherence to screening recommendations and more work is needed to ensure that 
adolescents are encouraged to be more active in being screened for STDs. 
 Additional studies have also implied that annual screening recommendations may not be 
the most effective screening interval for some populations.  The interval to re-infection and high 
re-infection rates suggest that multiple versus annual screening may be needed in some 
populations.  A study conducted by Burstein and others (1998) found that among an inner-city 
population of over 3,000 adolescent females (ages 12-19, 98% African-American), those with at 
least 2 positive Chlamydia test results had a median time to re-infection of 6.3 months and that 
25 percent of the re-infections were discovered within 4 months (Burstein et al., 1998).  In a 
review of Chlamydia screening recommendations performed by Kohl, Markowitz, and Koumans 
(2003) risk factors for repeat infection appear to be another aspect of Chlamydia and gonorrhea 
screening strategies that should be further explored.  High rates of re-infection may occur due to 
one or more of the following factors: partner selection patterns, sexual contact with untreated 
partners, and/or failure of individuals to modify high-risk sexual behaviors (T. Kershaw et al., 
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2004).  Some recommendations suggest screening women every 6 months or every 3 months for 
those with an initial infection (Kohl, Markowitz, & Koumans, 2003).  Hence, modifications to 
screening criteria for those at increased risk of Chlamydia and gonorrhea infection may change 
to every 6 months or so to improve diagnosing and treating these infections. 
 Similarly, recommendations also suggest that presumptive treatment for Chlamydia is 
needed when individuals are diagnosed with gonorrhea.  In 2002, the CDC renewed their 
recommendation that presumptive Chlamydia treatment in patients treated for gonorrhea (co-
treatment) should be the standard of care (MMWR, 2002).  A multi-site study conducted by Lyss 
and colleagues (2003) in Baltimore, Denver, Long Beach, Newark, and San Francisco found that 
among 3885 heterosexual men (2184) and women (1701), 19 percent of men (N=411) and 9 
percent of women (N=151) had a gonorrhea infection (Lyss et al., 2003).  Results indicated that 
of those infected with gonorrhea, 20 percent of the men and 42 percent of the women also had a 
Chlamydia infection.  The population from which this study is based upon were mostly young 
(median age, 25 years), members of racial/ethnic groups (59% Black, 16% Hispanic, 20% White, 
and 6% other.  Consequently, not only are individuals, especially women, being re-infected 
within months of initial infection, but many are also infected with both Chlamydia and 
gonorrhea. On the other hand, Gift and others (2002) found in a decision analysis with PID as the 
outcome that testing asymptomatic women for both Chlamydia and gonorrhea infections was 
more cost-effective than presumptive treatment for Chlamydia trachomatis. Accordingly, the 
need for Chlamydia and gonorrhea prevalence studies and ensuring that co-treatment or testing 
of both these infections is further researched should improve the standard of care.  
 Not only are there problems with screening programs, but investigation of STD screening 
criteria can assist with determining if these programs are effective or not.  There are two basic 
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questions when evaluating the effectiveness of STD screening programs and they are: (1) is the 
program effective in reducing the prevalence/incidence of disease complications; and (2) can 
benefits be obtained at a reasonable cost? (W. Miller, 1998).  Using a model that incorporates the 
relationship of clinic prevalence, a risk score based on risk assessment, and the probability of 
infection, Dr. William Miller discovered that prevalence-based chlamydial screening programs 
would be effective for clinics or areas with limited resources (W. Miller, 1998).  However, 
Miller does suggest that universal screening for screening programs without financial constraints 
should remain the gold standard for STD care.   
Another look at the review performed by Kohl and others (2003) found cost-effectiveness 
studies in Chlamydia screening programs to be scarce. Yet, some findings in this study revealed 
that universal screening was more cost-effective than no screening and that selective screening 
based on age (less than or equal to 25 years and less than 30 years) was more cost-effective than 
universal screening (Kohl et al., 2003).  These findings were highly dependent on the prevalence 
of Chlamydia in the population, risk factor prevalence, and testing procedure used. Moreover, 
Howell and researchers (1998) found that age-based screening provided the most cost-effective 
screening strategy within a family planning clinic in Baltimore, Maryland (Howell, Quinn, & 
Gaydos, 1998).  Thus, understanding a program’s effectiveness will also be essential in 
determining which STD screening criteria are best for specific testing facilities (public, private, 
etc.). 
 In conclusion, screening recommendations are essential to identifying asymptomatic and 
symptomatic infected individuals.  Many of the studies demonstrate that universal screening 
recommendations are needed in some populations, but other settings may need to determine the 
best criteria for their facility in developing guidelines for Chlamydia and gonorrhea screening.  
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The same may be true regarding methods for which clinics or doctors’ offices provide treatment 
for these infections and whether presumptive treatment is standard for these facilities.  Overall, 
STD screening recommendations are critical to diagnosing and treating Chlamydia and 
gonorrhea infections.  Therefore, evidence provided concerning success and failures of screening 
programs should be utilized in developing strategies that focus to improve the way in which we 
screen sexually active individuals for STDs. Moreover, the gaps in the literature regarding 
screening recommendations such as determining the cost-effectiveness of screening programs 
and predictors of disparities in screening strategies (i.e. differences by clinic, health care 
professional, etc.) warrant the need to research this area further. 
2.1.2. Studies Conducted that Investigate Issues Related to STD Healthcare Seeking 
 Understanding STD healthcare seeking behaviors is a critical prerequisite for reducing 
the number of STIs and cases of PID among young women.  Accordingly, a discussion of 
characteristics of STD healthcare-seeking behaviors of infected individuals and the screening 
behaviors of health-care providers are provided to reveal what is currently known about these 
issues. 
Individual Characteristics 
Socio-Demographic Factors 
 Studies researching characteristics of patients that impact STD care-seeking behavior are 
essential to improving STD care for women.  In general, younger age is considered to be a risk 
factor for STDs and thus is considered to be a negative factor that affects STD healthcare-
seeking (Amaro & Gornemann, 1991). Younger individuals may delay seeking care because they 
are less likely to perceive themselves at risk of infection or they fear seeking care due to parental 
notification or other issues related to the STD healthcare experience – such as, giving a sexual 
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health history, or having their confidentiality maintained) (Amaro & Gornemann, 1991; Barth, 
Cook, Downs, Switzer, & Fischhoff, 2002; Feroli & Burstein, 2003). On the other hand, the 1998 
and 1992 National Health and Social Life Survey (NHSLS) found that young persons were 
significantly more likely to report going to family planning clinics for STD care than adults 
(Brackbill, Sternberg, & Fishbein, 1999; Mosher & Aral, 1991).  In another study, older age (11th 
and 12th graders) was a strong predictor for STD screening among seventh through eleventh 
graders (Fiscus et al., 2004).  The literature also suggests that females are more likely to seek 
STD testing than males (Fortenberry et al., 2002; Rietmeijer, Bull, Ortiz, Leroux, & Douglas, 
1998).  As a result, the age and gender of individuals can affect many aspects of STD seeking 
behaviors such as where individuals seek treatment, perceptions of their susceptibility to sexually 
transmitted infections (STIs) , and the comfort level in discussing their sexual history.   
 Socioeconomic influences on healthcare-seeking behavior are also evident regarding 
STDs.  In a survey of over 2200 women (56% rural; 75% White; mean age of 25years) attending 
a Women, Infants, and Children (WIC) clinic in Missouri, researchers reported that the most 
frequent barriers to seeing a physician was having sex with a steady partner, not having 
symptoms, cost, and embarrassment (Crosby, Yarber, & Meyerson, 1999). A study conducted by 
Feroli and researchers (2003) found that lack of health insurance or the ability to pay for services 
and lack of transportation were barriers for seeking STD care in adolescents. In addition, one 
study found that low household income was associated with greater perceived barriers and lower 
self-efficacy among adolescent, African-American females (Fortenberry, 1997).  So, adolescents 
may defer seeking care for STDs because they may perceive costs or lack or health insurance as 
barriers, as well, they may not be able to get to clinics to be tested due to lack of transportation or 
financial constraints. 
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 One option for addressing the cost of diagnosing and treating STDs is the development of 
sexually transmitted disease clinics. Sexually transmitted disease clinics provide effective STD 
care services at a low-cost, yet, preferences to attend these clinics are low.  Literature suggests  
that women prefer private practice physicians or their own physicians for STD care rather than 
STD clinics (Barth et al., 2002; Brackbill et al., 1999). However, some studies do show positive 
aspects to attending STD clinics (Brackbill et al., 1999; Hogben et al., 2004).  In the study 
conducted by Hogben and researchers (2004), over 2000 face-to-face interviews were completed 
with community and health facility populations (mostly African-American and female) that 
assessed gonorrhea and HIV testing experiences in STD clinics.  These researchers concluded 
that factors related to treatment were more strongly associated with attending STD clinics rather 
than social factors (Hogben et al., 2004).  Study participants believed that STD clinics would 
cure their gonorrhea infection, provide staff that respected them, and receive care that was low-
cost.  Nonetheless, confidence in clinic care was associated with experience in seeking STD care.  
Social factors, such as the stigma of having an STD and confidentiality played a minor role in 
healthcare-seeking behavior (Hogben et al., 2004). Accordingly, it appears that some young 
women prefer seeking STD healthcare with private practice physicians and some prefer seeking 
care in STD clinics. So, there must be various factors that play a role in this decision, hence, 
further research is needed to understand STD care-seeking behaviors among young women. 
 Other individual characteristics that impact healthcare-seeking behavior are background 
factors such as educational level, age at first sexual intercourse, and psychosocial variables.  
These factors have been associated with STD acquisition among young women and may play a 
critical role in whether a young woman seeks care or not.  Not being able to read health literature 
(Chacko et al., 2004) and insufficient knowledge concerning STDs (Barth et al., 2002; Huppert 
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& Hillard, 2003; Tilson et al., 2004) can have a negative impact on STD health-care seeking 
behaviors. Although knowledge has not been found to improve STD healthcare seeking 
behaviors, it may assist with accurately perceiving risk and acknowledgement of symptoms 
among some women (Amaro & Gornemann, 1991; Fortenberry, 1997).  As a result, educational 
level and knowledge may not directly impact healthcare-seeking behavior as much as studies 
suggest, but may be helpful in developing STD testing programs for those who are less likely to 
obtain STD testing and care.  
Psychosocial Factors 
Psychosocial variables such as depression and social support can also affect STD 
healthcare-seeking behaviors.  Depression has been found to be a barrier for seeking care among 
diverse populations (Amaro & Gornemann, 1991) and it is even associated with other predictors 
of risky sexual behaviors such as early coital debut (Bachanas et al., 2002).  Depression and 
other areas of mental health (i.e. stress) may impact willingness to seek treatment and ability to 
perceive susceptibility to STDs. Since there is limited literature on the impact of stress and 
depression on STD testing behaviors, it will be critical to determine what effect this has on STD 
healthcare-seeking behaviors. 
On the other hand, social support may be a positive impact on STD healthcare seeking 
behaviors.  Fortenberry and others (1999) found that of the eighty percent of adolescents (ages 
13 to 20, >90% African-American) who reported receiving social support, the most frequent type 
of support was from friends and sex partners and included information about symptom 
interpretation and appropriate clinic use.  Additional social support received by these adolescents 
were being accompanied to their clinic visit and receiving emotional support (Fortenberry & 
Zimet, 1999).  Another study attempted to predict future STD-related care based upon 
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perceptions of social support among African-American adolescents.  This study reported that 
asymptomatic sexually experienced adolescents (n=145) who talked to their closest friend almost 
every day were more likely to have had STD related care in the past year, however, closeness to 
parents/guardians and participation in extracurricular activities were not associated with seeking 
STD services (Lowery, Chung, & Ellen, 2005). Therefore, social support is a factor that may 
improve STD testing behaviors among adolescents. 
Health-Related Factors 
Among women, there are also documented health-related reasons for delaying to seek 
STD care and treatment.  If symptomatic, some women wait to see if symptoms become worse, 
go away or persist (Aral & Wasserheit, 1998; Fortenberry, 1997; Hook et al., 1997; Mehta, 
Shahan, & Zenilman, 2000).  This may be due to uncertainty about symptoms or perceptions of 
low risk due to having a “steady” or “permanent” partner (Aral & Wasserheit, 1998; Banikarim 
et al., 2003).  Studies have also found that women take more time than men to seek treatment 
because before they are seeking social support, seeking information, and self-treating  (i.e. taking 
old antibiotics or douching to relieve symptoms) (Aral & Wasserheit, 1998; Fortenberry, 1997).  
Among 208 male and female African-American adolescents, some average interval times for 
seeking care (time from presumed infection to seeking care) was 9.6 days for symptomatic 
women, 5.8 days for asymptomatic women, 6.3 days for symptomatic men, and 7.3 days for 
asymptomatic men (Aral & Wasserheit, 1998).  These intervals demonstrate that symptomatic 
females wait longer to seek healthcare. So, it is important for providers and sexually active 
individuals who are symptomatic or asymptomatic to routinely participate in STD testing 
behaviors because delaying treatment can lead to other complications such as PID in women. 
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Another health-related factor that may impact STD testing behaviors is past STD history. 
One would argue that young women who have had an STD will be knowledgeable enough to 
seek testing if they have symptoms or engage in behaviors that would prevent them from 
acquiring an STD.  Yet, some studies have found that women with past STDs actually wait 
longer to seek care (Aral & Wasserheit, 1998; Fortenberry, 1997).  In addition, studies have also 
revealed that past STD history is associated with increased STD risk and risky sexual behaviors 
(i.e. multiple partners and engaging in unprotected sex) (DiClemente et al., 2002; T. Kershaw et 
al., 2004).  Thus, past STD history may be an important factor when investigating STD testing 
behaviors. 
Screening behavior can also be influenced by testing experience or provider attributes.  
Many adolescents report barriers to STD testing because of anxiety regarding possible 
procedures and diagnoses (Barth et al., 2002; Chacko et al., 2004; Rietmeijer et al., 1998; Tilson 
et al., 2004); the presence of parents during the examinations of adolescents which hinders 
confidential sexual risk assessments (Shih et al., 2004); and confidentiality issues concerning 
sexual health services or information in medical records or bills (Amaro & Gornemann, 1991; 
Feroli & Burstein, 2003; Shih et al., 2004). In addition, studies have found that provider 
characteristics also impact STD healthcare-seeking (Barth et al., 2002; Tilson et al., 2004).  
Females may prefer female providers for performing their genital exams (Barth et al., 2002; 
Dienes, Morrissey, & Wilson, 2004).  In some cases, the race of the provider may be important, 
but one study showed that African American teens’ opinions of the race of the provider may be 
obscured due to fact that they never have been seen by an African American physician (Dienes et 
al., 2004). So, healthcare experiences regarding STD testing and provider attributes are 
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fundamental aspects of seeking STD care that should be considered when attempting to 
understand what impacts this behavior.  
Another important barrier to STD testing that has been continuously documented among 
individuals is the stigma associated with STDs. Several studies show that the stigma associated 
with acquiring an STD and seeking testing for STDs in clinics appear to negatively impact the 
attitudes and perceptions that individuals have regarding STD testing.  In a qualitative study 
examining the concept of stigma to STIs in the deep south, Lichenstein (2003) reported that 
stigma was related to promiscuous sexual behavior of women (looked down upon by health 
workers due to religious beliefs), negative perceptions of STD clinics as places for Blacks (racial 
stigma - Blacks were poorer, had no health insurance, and mostly the ones who had STDs), and 
confidentiality (fear that others would see you at the clinic and talk about you) (Lichenstein, 
2003).  Thus, stigma can be a serious social-psychological barrier to seeking care for individuals, 
especially Black females. 
 In a qualitative study conducted by Barth and researchers (2002), stigma was found to be 
a barrier among college students seeking STD testing.  In addition, perceptions regarding 
possible negative consequences of testing such as others seeing them, receiving a positive test 
result, and embarrassment are also other issues that may limit STD care-seeking (Barth et al., 
2002).   Fortenberry and colleagues (2002) also found that among over 1900 males and females 
(mean age = 24.9 years old) in 7 cities, STD-related stigma (reflection of the participant’s 
expectation of isolation and adverse social judgment associated with STDs) was associated with 
a decreased likelihood of being tested for gonorrhea during the past year.  Other variables 
associated with gonorrhea testing were female sex, younger age, enrollment from a health 
facility, health service use in the past year, suspicion of gonorrhea, and low levels of STD-related 
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stigma (Fortenberry et al., 2002).  Accordingly, STD stigma appears to be a significant barrier to 
STD testing among all individuals. 
 For the most part, there appear to be many obstacles to seeking STD care for young 
women.  Several recent studies have elicited adolescents’ opinions on what type of services they 
would prefer when seeking STD testing and care.  In one study, Blake and others (2003) 
conducted focus groups with youth from Job Corps and Department of Youth Services sites 
(ages 15-24 years; 32 males, 23 females; 29% White, 27% Hispanic, 22% African-American, 
15% other race, and 7% Asian) regarding barriers to and motivators for Chlamydia screening.  
Results indicate that common barriers to testing were fear of someone knowing they got tested or 
tested positive, fear of acquiring an STD, and fear of AIDS.  Motivators for screening were 
improving knowledge about Chlamydia and its effects, availability of urine testing, providing 
easy treatment, offering confidential services, and using a home Chlamydia test (Blake, Kearney, 
Oakes, Druker, & Bibace, 2003). In another study by Tilson and researchers (2004), diverse 
adolescents (ages 14-24) reported that ideal features of STD services were locations close to 
familiar places, having extended hours, and the availability of urine-based screening.  Some 
barriers mentioned in this study were costs of STD services, lengthy wait times, language 
barriers at STD testing sites, perceived discrimination, and perceived judgment from providers 
(Tilson et al., 2004). 
 Lastly, in a study investigating features of STD services that are important to low-
income African-American adolescents, researchers found that African-American females 
deemed provider attributes (providers who give clear explanations, answer questions, and have 
good medical knowledge) and confidentiality as most important (Lane et al., 1999).  Other 
important features were convenient clinic hours and timing of appointments. However, these 
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adolescents did not prefer school-based health centers for STD care but prefer traveling to a 
health center outside their neighborhood (Lane et al., 1999).  Hence, these studies provide 
evidence that adolescents know what they want and that there are numerous barriers to STD 
testing that must be addressed in order to improve diagnosis and treatment of STIs. 
In conclusion, individual characteristics of young women are essential to understanding 
STD testing and seeking behaviors among this population.  Socio-demographic factors such as 
age, gender, race, educational level, and income seem to affect seeking behaviors of young 
women.  Many of the decisions that individuals make to obtain care are based on what they know 
or if they can afford to get tested.  Other factors such as past STD history, stigma, testing 
experiences, and provider attributes are also critical to ensuring that young women seek care in a 
timely fashion and without fear of engaging in this health preventive behavior.  In general, most 
adolescent women would like quality STD services that are confidential, easy, friendly, and 
accessible.  As a result, examining the individual characteristics of young women’s healthcare 
seeking behavior is essential for reducing the incidence of STIs within this population. 
Health-Care Provider Characteristics
Recently, the role of providers in the diagnosis and treatment of STDs has become a 
subject of interest for clinicians and researchers. Investigating provider and service-related 
factors that promote or hinder health care seeking is critical in studying these STD testing 
behaviors (Amaro & Gornemann, 1991).  A primary concern regarding physicians is the reported 
low rates of STD screening by physicians.  A recent survey of primary care physicians (87% in 
private practice; mean age of 46 years; 81% White, 13% Asian, 4% African-American) 
documented low rates of routine Chlamydia screening among women (between 20 and 30%) 
which are at levels well below practice guidelines (St. Lawrence et al., 2002). Moreover, case 
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reporting levels by physicians for Chlamydia were low and thus partner notification practices 
were insufficient (St. Lawrence et al., 2002). Another study examining STD screening by 
obstetricians and gynecologists found that these specialists screen women at a higher rate than 
other physicians, yet, only about half of obstetricians and gynecologists screened non-pregnant 
women for Chlamydia or gonorrhea (Hogben et al., 2002). Other studies also reveal that STD 
screening among adolescent females is lower than recommended CDC guidelines (Ellen et al., 
2000; Millstein, Igra, & Gans, 1996; Torkko, Gershman, Crane, Hamman, & Baron, 2000).  
Therefore, low screening rates by physicians warrant a better understanding of provider 
attributes that impact STD healthcare-seeking. 
An additional examination of Chlamydia screening practices used HEDIS data from 1999 
to 2001 to evaluate rates among sexually active women in commercial and Medicaid health 
insurance plans.  This CDC study also found low rates of Chlamydia screening among enrollees 
in both commercial and Medicaid plans (Shih et al., 2004).  Although Chlamydia screening rates 
were higher among Medicaid enrollees, possibly due to health-care provider’s beliefs that 
Medicaid patients are at increased risk for STDs, overall rates were still below recommended 
CDC guidelines for sexually active women. Consequently, low rates of screening practices 
among providers, even when considering access to care, is insufficient and should be addressed 
immediately for the enhancement of women’s health services. 
During STD screening practices, it is standard to obtain a sexual history of the individual 
and then test them for STDs based on their risk.  Documented characteristics of providers that 
regularly take a sexual history are female gender, obstetrics/gynecology specialty, and provider 
comfort level in discussing sex (Torkko et al., 2000). Characteristics of providers associated with 
regularly testing adolescent females for Chlamydia are female gender, regularly discussing STD 
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prevention, and regularly discussing limiting the number of patients’ sex partners (Torkko et al., 
2000).  Another study conducted by Cook and colleagues (2001) assessed barriers to screening 
sexually active women for Chlamydia among physicians in Pennsylvania. This study found that 
physicians were more likely to screen for Chlamydia during a routine gynecologic examination if 
they were female, worked in a clinic versus a solo private practice, worked in a metropolitan 
area, or had a patient population of African-Americans that was greater or equal to 20 percent 
(Cook et al., 2001).  Therefore, further research should investigate why female providers and 
certain specialties screen young women more frequently than other providers because 
understanding these factors can aid researchers in improving adherence to STD screening 
recommendations. 
Stigmas or opinions held by providers may also affect their screening practices or impact 
the way in which young women access services by these providers.  In the aforementioned study 
regarding an investigation of STIs in the deep south, findings revealed that health workers who 
had religious convictions may have inadvertently discouraged screening for some individuals 
based on their beliefs regarding how women should behave morally in relationships 
(Lichenstein, 2003).  Another study found that screening by physicians depended on their beliefs 
that most 18-year-old women in their practice were sexually active, feeling responsible for 
providing information about the prevention of STDs to their patients, or knowing that screening 
for Chlamydia prevents PID (Cook et al., 2001). So, the way providers think about sexuality or 
STD prevention behaviors seems to impact whether providers follow screening 
recommendations or not.  This area of the literature needs to be further explored because this is 
critical to improving health services to young women. 
 38
Studies examining provider behaviors and their effects on health-care seeking have also 
provided some insight on utilization of STD care services.  A survey of providers and 
adolescents regarding STD screening found that clinicians barriers to providing adequate 
screening included concern over lack of confidentiality, inadequate facilities for performing a 
pelvic examination, clinician discomfort with discussion of sexual behavior, and discomfort with 
performing pelvic examinations (Huppert & Hillard, 2003).  Additionally, physician beliefs that 
their patients are not sexually active, the prevalence of Chlamydia is low, and that screening for 
Chlamydia does not prevent PID are also barriers to clinicians adherence to STD screening 
recommendations (Huppert & Hillard, 2003).  The cost-effectiveness of screening, a concern 
created by the number of false-positive tests, was another reason for providers being less likely 
to offer Chlamydia screening to adolescents (Huppert & Hillard, 2003).  Another area of concern 
is effective communication by providers.  Providers may have difficulty discussing sexuality 
issues with or acquiring sexual histories of patients because of their comfort level or due to time 
constraints in their schedule (IOM, 1997).  The provider communication style is a crucial factor  
in patient satisfaction, adherence to regimens, and aspects of other health behaviors (Amaro & 
Gornemann, 1991).  As a result, clinician barriers to screening such as inadequate facilities to 
perform testing and difficulty in discussing sexual issues leads to non-adherence to screening 
recommendations and ultimately missing young women who potentially have an STD and need 
to be treated.  
 Another area to consider regarding adherence to STD screening recommendations would 
be system factors within clinic or doctor’s office settings that hinder effective STD screening 
practices. In a study evaluating a urine-based Chlamydia screening program, difficulty in 
implementation was found to be a barrier to adherence to screening recommendations (Chacko et 
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al., 2004).  Issues related to absence of protocols for collecting urine specimens confidentially, 
primary care physicians not taking sexual histories, lack of awareness of Chlamydia infection in 
their practice, low levels of knowledge regarding urine tests, and reluctance of staff to be 
involved in STD screening were barriers to implementing an effective screening program in this 
study (Chacko et al., 2004). So, there appear to be many barriers for providers concerning the 
screening of women which is an area that needs to be studied in order to understand how system 
factors can be modified to foster improved screening practices. 
In an evaluative examination of STD clinics in three cities, researchers found that initial 
notification procedures for women with positive Chlamydia or gonorrhea tests delayed treatment 
(Wong, Berman, Furness, Gunn, & Peterman, 2005).  Results showed that the median time to 
treatment was 18 days in Washington, D.C., 8 days in Los Angeles, and 14 days in San Diego.  
To address poor notification practices, an intervention in San Diego was implemented which 
improved notification to patients (within 24 hours of laboratory receipt). In addition, notification 
procedures were enhanced by maintaining a logbook that tracked progress and treatment 
compliance.  Overall, notification days in San Diego were reduced from 14 days to 7 days 
(Wong et al., 2005).  Thus, health system factors such as procedures for collecting specimens 
and notifying women of infections may cause providers to be modest regarding screening 
recommendations and cause delays for individuals who need to return for treatment. 
 In summary, provider characteristics are essential aspects of STD screening and testing 
practices that an individual cannot control.  Low rates of screening by providers demonstrate that 
there must be several barriers to screening or insufficient knowledge regarding the dire need for 
STD screening among sexually active individuals.  Barriers such as not being comfortable taking 
a sexual history to not believing that the population served is at risk for disease are issues that 
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need to be more aggressively addressed in medical training.  Other problems regarding health 
system factors that impede the screening process should also be modified to improve screening 
practices within medical facilities.  In general, the stigma attached to sexuality, female providers 
being more inclined to perform STD screening during a gynecological exam, and other barriers 
mentioned above are all factors which impact STD screening behaviors.  Although the proposed 
study will not examine provider characteristics and their affects on STD seeking behaviors, the 
information presented is evidence that provider and health system characteristics are major 
contributors to the STD healthcare utilization of young women. 
2.1.3. STD Screening and Care Outside of Clinic Settings 
 The concept of screening outside of clinic settings is a new phenomenon that has 
occurred as a result of the need to improve client participation in STD screening programs.  This 
idea aims to provide confidential screening that can be completed without invasive techniques. In 
a small, telephone-based study (n = 120) that assessed young adults’ (ages 18 to 25; 41% White, 
33% Latino, and 22% Black) attitudes, beliefs, and feelings about testing outside of clinic 
settings found some encouraging information.  These individuals reported that they would use 
the self-test urine screening kits if available and that advantages of testing outside of clinic 
settings were privacy, increased testing, convenience, and possibly lower costs (Ford, Jaccard, 
Millstein, Viadro et al., 2004).  Some of the disadvantages of testing outside of clinics were 
doubts about test accuracy, doubts that young people with positive tests will get treated, and 
doubts that the test would be used among people at risk of infection (Ford, Jaccard, Millstein, 
Viadro et al., 2004). In addition, most respondents said they would call for results and seek 
treatment if they have a positive test, however, a clear disadvantage would be not being able to 
have a face-to-face discussion with provider about a positive test and possible negative emotions 
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from a positive test (Ford, Jaccard, Millstein, Viadro et al., 2004). So, testing outside of clinic 
settings appears to have both advantages and disadvantages regarding testing behaviors, 
however, this initiative could provide an innovative method that encourages testing within young 
women. 
One setting that is of primary interest as an alternative STD screening strategy regarding 
adolescent and young populations is schools.  Evidence suggests that STD testing in schools is 
both feasible and acceptable to parents (D. Cohen, Nsuami, Martin, & Farley, 1999) and students 
(D. Cohen et al., 1999; Coyne-Beasley, Ford, Waller, Adimora, & Resnick, 2003; Kent, 
Branzuela, Fischer, Bascom, & Klausner, 2002).  Studies also show that expansion of STD 
screening programs in school settings was helpful in diagnosing and treating asymptomatic 
Chlamydia and gonorrhea infections among girls and boys (D. Cohen et al., 1999; Kent et al., 
2002).  In the Cohen study (1999), researchers were also able to reduce re-infections and the 
prevalence of Chlamydia among boys in these schools(D. Cohen et al., 1999).  An economic 
evaluation of a school-based STD screening program in New Orleans which used a decision tree 
analysis found that this type of program reduced Chlamydia prevalence, reduced the occurrence 
of PID and other sequelae, and resulted in a net cost-savings to the health-care system (Wang, 
Burstein, & Cohen, 2002).   Although there is some concern regarding confidentiality for school-
based screening (i.e. a minor being able to legally consent to STD testing), the literature 
presented demonstrates the utility of school-based STD screening programs as another strategy 
to improve diagnosis and treatment of STIs among young populations as well as reduce 
incidence and re-infection of STIs. 
 Another possible venue for STD testing outside of clinics is testing in community 
settings.  In an attempt to reach populations in their neighborhoods, Kahn and researchers (2003) 
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conducted an innovative community-based screening strategy in Baton Rouge, Louisiana (a 
collaboration of the health department and two community-based organizations).  Within the 
Kahn study, a mobile van was used to offer free promotional health screenings to the general 
public in an assortment of settings such as parking lots of bars, churches, restaurants, stores, and 
vacant lots.  Results from this study revealed that among over 2200 urine samples, 8.3 percent 
were positive for Chlamydia (9.9% in females, 5.5% in males, >85% asymptomatic) and 4.9 
percent were positive for gonorrhea (5.3% in females, 4.1% in males, >65% asymptomatic) 
(Kahn, Moseley, Thilges, Johnson, & Farley, 2003).  In addition to identifying asymptomatic 
chlamydial and gonorrheal infections and co-infections, over 90 percent of those with a bacterial 
infection were treated.  A street survey of 389 individuals from the community administered 
during this study indicated that 97 percent thought that neighborhood STD testing strategy was a 
“good” or “very good” idea (Kahn et al., 2003).  A similar Chlamydia and gonorrhea screening 
study in San Francisco (a collaboration between a local faith-based organization and the San 
Francisco Department of Health) utilized youth trained to provide STD prevention education to 
at-risk youth (Moss, Gallaread, Siller, & Klausner, 2004).  This initiative encouraged individuals 
under 25 years of age to attend community testing venues (i.e. barber shops, etc.) to be screened 
for STDs.  The results of this 6-month initiative were promising because out of 450 youth 
screened, 9 percent tested positive for Chlamydia, gonorrhea, or both (Moss et al., 2004).  In 
addition, all those infected received treatment in the field and some even accepted treatment for 
their partners (Moss et al., 2004). Thus, STD screening programs that utilize community settings 
emerge as a successful strategy for identifying asymptomatic STIs, providing convenient access 
to STD services, and treating infections. 
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Testing outside of clinic settings also implies that testing procedures used will be 
convenient, easy to perform, and be specific for detecting chlamydial and gonorrheal infections.  
With the development of NAATs, sensitive and specific, noninvasive testing is available as a 
useful option in alternative STD testing programs. One testing procedure that has been 
researched for acceptability and feasibility outside of the normal clinic setting is urine-based 
screening.  In a population of high-risk adolescents from a detention center (>60% African 
American), a substantial number of asymptomatic Chlamydia and gonorrhea infections were 
diagnosed and treated with first-void urine screening (Oh et al., 1998).  Emergency departments 
are another setting where urine-based screening can be used in an efficient manner and be 
acceptable to most patients (Monroe, Wiess, Jones, & Hook, 2003).  In addition, urine-based 
screening for STDs has also been used in substance abuse settings which can be an opportune 
time to diagnosis and treat at-risk populations (Lally et al., 2002).  As a result, evidence 
demonstrates that urine-based screening in various settings can be an option for acceptable and 
feasible STD testing, especially in places where STD testing is not the norm. 
Another setting that provides an opportunity for STD care is the emergency department 
(ED).  Although emergency rooms are located within a hospital or clinic setting, they are still 
considered to be a location that is different from the normal clinic environment. Many 
emergency departments are sites for primary care services, including STDs in populations that 
are underserved or located in the inner-city.  Research suggests that persons who access 
emergency departments in need of STD care are mostly unknowledgeable of available STD 
clinic services in their community, unable to go because of restricted hours of STD clinics, 
embarrassed to go to STD clinics, or misclassified their symptoms as not STD-related (Mehta et 
al., 2000).  In a study of an inner-city Baltimore, Maryland ED population indicated that those 
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who mostly attended this ED were single females, had health insurance, and had a history of an 
STD in the past year.  Men were more likely to have no usual source of care and a past STD 
(Mehta et al., 2000).  Hence, EDs represent a setting that may be overburdened by STD care and 
should be used as a potential source to enhancing access to comprehensive STD healthcare that 
is convenient and provides quality service.  In addition, population characteristics of emergency 
rooms may be important predictors for targeting screening methods based upon the health risks 
of the community. 
 The most recent and popular alternative to clinic screening presented in STD prevention 
literature that is outside of the clinic setting is home sampling.  Home STD testing or home 
sampling can be used to improve testing behaviors and individual attitudes toward STD testing.  
Several studies indicated that home sampling may be a valuable option in STD control efforts 
(Bloomfield, Kent, Campbell, Hanbrook, & Klausner, 2002; Tebb, Paukku, Pai-Dhungat, 
Gyamfi, & Shafer, 2004).  Many of these studies included only men and used urine-based 
screening techniques to facilitate this process. However, the latest studies focus on recruiting 
women into home sampling interventions that use self-collected swab samples as the mechanism 
for testing specimens.  These studies also reveal that using self-collected swab samples in 
community settings are acceptable and feasible (Richardson et al., 2003; Smith et al., 2001).  In a 
study of 512 African American adolescent females in a non-clinical STD/HIV prevention 
program, researchers found that all participants chose vaginal swabs (versus a pelvic 
examination) as their preference for an STD testing method (Smith et al., 2001).  The results of 
testing in this population discovered that approximately 20 percent of females were infected with 
Chlamydia or gonorrhea and that patient-obtained vaginal swabs were adequate and appropriate 
specimens for STD screening sites that are non-clinical (Smith et al., 2001).  In general, vaginal 
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swab sampling (or self-sampling) may be helpful in facilitating STD screening among women 
who are at high-risk for infections or who may not readily access health services (i.e. may be 
fearful of pelvic exams, stigma, or other barriers).  In addition, vaginal swab sampling is also 
useful in determining the prevalence of infections in hard to reach populations (Richardson et al., 
2003).  Therefore, a promising testing alternative to STD testing in community settings may be 
home testing.  However, the overall success of this alternative is still being evaluated. 
Additional studies have also investigated STD testing programs outside of clinic settings.  
When given a choice of home urine-based screening or vaginal swabs for STD testing, a group 
of sexually active females (ages 13 to 20 years, 53% African-American, 30% White, 26% Asian, 
20% Latino) favored home urine-based screening (Tebb et al., 2004).  In addition, adolescent 
females who believed they were at-risk for infection preferred testing at home than attending a 
clinic (Tebb et al., 2004).  In a comparable study that assessed the preference of self-collected 
vaginal swabs or first-void urine test in detecting chlamydial infections among approximately 
1300 female army recruits (mean age was 20.3 years, 48.3% White, 35.7% Black, 13.1% other 
races), urine was preferred over swab testing in a clinical setting (Hsieh, Howell, Gaydos, 
McKee, & Quinn, 2003). In this study, there were no racial preferences for urine testing, 
however, self-collected swab testing was associated with being White and having had sexual risk 
behaviors in the past 3 months (Hsieh et al., 2003). Thus, home sampling, especially if urine tests 
are available, appear to be the most acceptable test among sexually active females and can be 
helpful in diagnosing asymptomatic STIs. 
 In conclusion, testing outside of clinic settings appears to be the newest and most 
acceptable method for encouraging STD testing among young women.  Much of the literature 
mentioned, urine-based screening as the most convenient and easiest procedure for young 
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women to participate in STD screening.  Some STD screening programs prefer home vaginal 
swab sampling for women because there may be some difficulty in storing urine or other issues 
related to getting the urine to a lab for testing.  In addition to these easier sampling procedures, 
STD testing in the community can assist with access issues and possibly persuade those who are 
less likely to seek screening to participate in places they deem as non-threatening (i.e. places in 
the community, etc.). So, most studies that discuss STD testing outside of the clinic setting 
demonstrate that women see many advantages to testing at home.  On the other hand, there may 
be some disadvantages to testing outside of the clinic settings. One article mentioned that testing 
initiatives outside of clinic settings could lack private personal interactions with healthcare 
professionals who can discuss and recommend testing (Ford, Viadro, & Miller, 2004).  There 
may also be disadvantages related to return treatment if no treatment is offered in the community 
and difficulties in relaying STD-preventive information to promote healthier sexual behaviors.  
Thus, STD testing outside of clinic settings may prove to be a great option for providers to 
improve access to care for hard-to-reach populations, track prevalence of infections and 
treatment of patients, and motivate individuals to participate in STD screening programs. 
However, there are still some challenges to implementing a program that exhibits overall 
effectiveness. 
2.1.4. Background Information Related to Racial Disparities in STD Rates 
Within the population of study participants for this research, approximately 60 percent 
are young African-American women under the age of 21.  Young, African-American females 
suffer disproportionately from STDs in the US and the most optimal method to address these 
disparities would be to determine what factors impact their behaviors.  Research has suggested a 
myriad of explanations for the increased STD risk among young African-American females. 
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 Demographic characteristics such as age, gender, race, and socioeconomic status (SES) 
have been principle areas of research regarding the STD/HIV epidemic.  These areas have also 
been researched regarding racial disparities in STD rates.  Young age indicates various 
developmental changes that occur physically and cognitively among young women.  During 
puberty, the columnar epithelium lining of the cervix is exposed and cells on this lining are 
particularly susceptible to an attack by chlamydial and gonococcal organisms (Shrier, 2004).  In 
addition, national research studies indicate that African-American girls sexually mature earlier 
(undergo puberty) and have earlier ages at menarche (Chumlea et al., 2003; Sun et al., 2002).  
There may also be social cognitions at puberty which may foster feelings of sexual arousal 
(O'Sullivan, Meyer-Bahlburg, Nat, & Watkins, 2000) and being physically mature may provide 
opportunities for boys to persuade them to engage in sexual intercourse (W. Doswell & B. 
Braxter, 2002; L. O'Sullivan, H. Meyer-Bahlburg, R. Nat, & B. Watkins, 2000). Thus, earlier 
physical maturity among young African-American females might foster premature sexual 
activity which may increase their chances of acquiring an STD. 
 Early sexual intercourse (also known as early coital debut) has also been associated with 
increased risk for STDs among young African-American females. Having sex at an early age can 
affect life long number of partners and increase one’s opportunity for having a history of an STD 
(Greenberg, Magder, & Aral, 1992; Seidman, Mosher, & Aral, 1994). Some of the most common 
influences on the timing of sexual intercourse for young African-American adolescents other 
than pubertal development are peer norms about having sex (W. M. Doswell & B. Braxter, 2002; 
Marin, Coyle, Gomez, Carvajal, & Kirby, 2000; L. F. O'Sullivan, H. Meyer-Bahlburg, R. Nat, & 
B. X. Watkins, 2000; Rosenthal et al., 2001; Santelli et al., 2004), self-esteem (Goodson, Evans, 
& Edmundson, 1997; Spencer, Zimet, Aalsma, & Orr, 2002), personal values (Paradise, Cote, 
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Minsky, Lourenco, & Howland, 2001), family characteristics (Goodson et al., 1997; McBride, 
Paikoff, & Holmbeck, 2003), and religious affiliation (Goodson et al., 1997; Paradise et al., 
2001).  So, although there are numerous issues that affect early coital debut in young African-
American females, no evidence has been provided by these studies to explain the increased STD 
rates in this population.  
 Several population-based and community-level studies have examined the influence of 
race and SES on increased STD risk among young African-American females. Race has 
traditionally been associated with the incidence of STDs and has also been used as a risk marker 
for both sexual and healthcare-seeking behavior (Aral, Fullilove, Coutinho, & Van Den Hoek, 
1991).  Risk markers are different from risk factors because they describe independent variables 
such as number of sexual partners and alcohol use which have an indirect relationship causing 
the outcome of interest (Padian, Shiboski, & Hitchcock, 1991).  Therefore, race can be 
considered a risk marker and not a risk factor for increased risk of STDs in young African-
American women because African-American race alone is not associated with acquisition of 
STDs. 
Additionally, there are also several aspects of SES which have been linked with STD risk 
in African-American women.  Characteristics of young African-American women such as low 
parental income (Newbern, Miller, Schoenbach, & Kaufman, 2004), unemployed parental status 
(Sionean, DiClemente, Wingood, Crosby, & Cobb, 2001), low maternal education (Newbern et 
al., 2004), and broken family structure (Sionean et al., 2001) have been linked with STD risk 
within this population. Research has also used innovative indicators of SES and found that the 
lack of social capital, living in poverty, and income equality correlated with Chlamydia 
acquisition (Holtgrave & Crosby, 2003).  Also, low rates of social cohesion such as the closeness 
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of the neighborhood (Ellen, Jennings, Meyers, Chung, & Taylor, 2004) and high “broken 
windows” index which is a non-traditional measurement of SES that examines housing quality, 
abandoned cars, graffiti, trash, “off-sale” alcohol outlets, and public school deterioration (D. 
Cohen et al., 2000) were associated with a high prevalence of gonorrhea in these studies.  As a 
result, these measures of SES demonstrate the complexity of SES and how it may impact the 
increased risk for STDs among young African-American women. 
 Research investigating STD knowledge and attitudes of young African-American females 
has also revealed some surprising information regarding STD disparities.  An assessment of 
sexuality education guidelines provided by the Sexuality Information and Education Council of 
the United States (SIECUS) found low STD knowledge and inaccurate risk perceptions of STDs 
among a population comprised mostly of young African-American females (Clark, Jackson, & 
Allen-Taylor, 2002).  Even having a past history of an STD which is believed to increase one’s 
knowledge of STDs, did not have an effect on adopting STD/HIV prevention behaviors (Clark et 
al., 2002; DiClemente et al., 2002).  Therefore, young African-American females’ STD 
knowledge may either be low or not sufficient enough to motivate changes in their behaviors. 
 Attitudes toward and perceptions of STDs are areas where researchers have attempted to 
explain STD disparities among young African-American women.  In one study, over 500 young 
African-American females were found to have low percentages of STD worry (part of the 
construct of perceived threat which creates worry and may be an indication of dissonance – 
possibly a strong motivating factor for change), report infrequent communication with partner, 
and have low perceived ability to negotiate condom use (Crosby, DiClemente, Wingood, 
Sionean, Harrington, & Davies, 2001). Another study of over 400 urban female adolescents 
(44% African-American) found that about half the participants misperceived their risk for 
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precarious sexual behaviors (T. S. Kershaw, Ethier, Niccolai, Lewis, & Ickovics, 2003).  
Approximately 42 percent of the participants were at high risk for unsafe sexual behaviors (e.g. 
unprotected sex with multiple partners), but 65 percent believe that their behaviors were slightly 
or not at all risky (T. S. Kershaw et al., 2003). Ironically, those who perceived themselves at 
higher risk were more likely to not use condoms, have had multiple sex partners, have had sex 
with a risky sexual partner, have an STD diagnosis, have higher aggregate sexual risk in the past 
year and have low STD risk knowledge (T. S. Kershaw et al., 2003). Thus, young African-
American females appear to not be worried about STDs and have inaccurate perceptions 
regarding risks of STDs which is not any different from most adolescents.   
 Numerous studies have examined whether sexual behaviors explain the disparities in 
STD rates among young African-American females (Boyer et al., 2000; K. Miller, Forehand, & 
Kotchick, 2000; Ramirez-Valles, Zimmerman, & Newcomb, 1998). Yet, there are no studies 
which offer any concrete evidence demonstrating a relationship between riskier sexual behaviors 
of African-American females with STD acquisition. There is even one study that shows African-
American females engaging in less riskier sexual behaviors (Quadagno, Sly, Harrison, Eberstein, 
& Soler, 1998).  So, the lack of association between riskier sexual behaviors among African-
Americans has led to studies examining partner choices by African-American women and 
corresponding sexual networks. 
 Research investigating partner choices and sexual networks among African-American 
women suggests that there are limited, eligible African-American men which may change norms 
related to engaging in traditionally monogamous relationships (Harawa, Greenland, Cochran, 
Cunningham, & Visscher, 2003; Wingood & DiClemente, 1998).  In addition, African-American 
women appear to engage in powerless (Rickert, Sanhvi, & Wiemann, 2002), concurrent 
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(Adimora et al., 2002; Kelley, Boawski, Flocke, & Keen, 2003), and socioeconomically 
imbalanced relationships which may place them at increased risk for STDs.  These sexual 
relationships also appear to be immersed within geographical areas that have high percentages of 
African-Americans living in them and high rates of Chlamydia and gonorrhea (a sexual network 
explanation).  As a result, engaging in unfavorable relationships and possibly choosing partners 
within high-risk areas are causes for concern regarding the increased risk for STDs among young 
African-American females.  
 Overall, young African-American women have increased risk for STDs.  Yet, there is not 
one explanation for why STD rates are higher among this population.  Young African-American 
women do not engage in riskier behaviors such as drug or alcohol use nor participate in riskier 
sexual behaviors.  Nevertheless, a combination of many factors such as early age at first 
intercourse, low SES, low social and family support structures, cultural attitudes, sexual 
networks, and the imbalance in the ratio of African-American men to women may all play a role 
in this epidemic.  Thus, when exploring methods to improve STD healthcare-seeking behaviors 
of populations, taking these disparity issues into account may prove to be essential to reducing 
the incidence of PID among all young women. 
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3. CHAPTER III. 
3.1. THEORETICAL FRAMEWORK 
 
3.1.1. The Health Belief Model 
 
 This chapter will include a discussion of (a) the historical origins of the Health Belief  
 
Model (HBM); (b) an explanation of HBM components and their use in predicting STD- 
 
preventive and screening behaviors; (c) the applicability of the HBM among African-American  
 
populations; and, (d) the adapted model that will be used to explain the two main outcomes  
 
of this study.    
 
Historical Origins 
 
 The Health Belief Model (HBM) was initially developed by social psychologists during 
the 1950s to understand a lack of participation in disease detection and prevention programs 
established by the U.S. Public Health Service.  Later the HBM was expanded to understand 
people’s responses to symptoms and their adherence to medical regimens (Janz, Champion, & 
Strecher, 2002).  The HBM is one of a class of theories known as a value-expectancy theories. 
As such, value-expectancy theories of health-related behavior, explain behavior in terms of the 
desire to avoid illness or to get well (value) and the belief that a specific health action available 
to a person prevents illness (expectation) (Janz et al., 2002).  The expectation component is 
represented by the individual’s estimate of personal susceptibility to and severity of an illness, 
and of the likelihood of being able to reduce that threat through personal action (Janz et al., 
2002). The HBM has been one of the most widely used psychosocial approaches to explaining 
health-related behavior (Rosenstock, Strecher, & Becker, 1994). 
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HBM Components and Their Use in Predicting STD-Preventive and Screening Behaviors 
 The first documented use of the HBM was in 1958 by Hochbaum who studied probability 
samples of more than 1200 adults in 3 cities that conducted tuberculosis (TB) screening 
programs in mobile X-ray units (Rosenstock et al., 1994).  One’s “readiness” to obtain an X-ray 
was assessed by their beliefs that they were susceptible to tuberculosis and their beliefs in the 
personal benefits of early detection (Rosenstock et al., 1994).  Since Hochbaum’s survey, 
researchers have expanded and clarified the model to include preventive actions such as illness 
behaviors and sick-role behaviors (Rosenstock et al., 1994).  Generally, people are believed to 
take action to prevent, screen for, or control ill-health conditions if they regard themselves as 
susceptible to the conditions, if they believe it would have potentially serious consequences, if 
they believe that course of action available to them would be beneficial in reducing their 
susceptibility to or the severity of the condition, and if they believe that the anticipated barriers 
to (or costs of) taking the action are outweighed by its benefits (Janz et al., 2002). 
 The components of the HBM (Figure 3.1) are described below. 
INDIVIDUAL PERCEPTIONS 
Perceived Susceptibility 
 Perceived susceptibility or perceived risk refers to one’s subjective perception of the risk 
of contracting a health condition (Janz et al., 2002).  The acceptance of personal susceptibility or 
risk of a condition varies widely by individuals.  Individuals may deny the possibility of 
contracting a condition, admit the possibility of disease, or express feelings of real danger for 
contracting the condition (Rosenstock, 1974).  Perceived susceptibility is also believed to be a 
motivating factor for attitude or behavior change in the HBM (Sydney, Patterson, Hadley, 
Barnard, & Alpert, 2000). 
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Figure 3-1     The Health Belief Model as Predictor of Preventive Health Behavior 
                       (Becker, Drachman, & Kirscht, 1974) 
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The current study examines the relationship between perceived susceptibility and STD testing 
behaviors. 
Perceived Severity 
 Perceived severity refers to one’s convictions concerning the seriousness of a health 
condition. The degree of seriousness also varies by individuals. Individuals may perceive the 
severity of a health condition based on its medical or clinical consequences (e.g. death, reduced 
physical or mental functioning, or pain) or social consequences (e.g. effects of disease on one’s 
job, family life, and social relations) (Rosenstock, 1974).  The current study investigates whether 
perceived severity is associated with STD testing behaviors. 
 Perceived threat has been noted as a critical initial cognitive step in the course of taking 
on a recommended action to reduce the threat of a disease or illness.  The HBM views perception 
of threat as a combination of two factors: an individuals’ perception that he/she is susceptible to 
the disease or illness and a perception that the illness is severe, where severity can consist of 
medical, clinical, financial, and social consequences (Rosenstock et al., 1994).  
MODIFYING FACTORS 
 Modifying factors are diverse variables that indirectly influence health-related behaviors 
and may affect an individual’s perceptions.  These factors consist of demographic (e.g. age, 
gender, race, education, income, etc.), socio-psychological factors (e.g. personality, social class, 
peer and reference group pressure, etc.), and structural factors (knowledge about the disease, 
prior contact with the disease, etc.).  Socio-demographic factors, especially educational 
attainment, are believed to indirectly influence the perception of susceptibility, severity, benefits, 
and barriers (Rosenstock, 1974; Rosenstock et al., 1994).  The current study examines whether 
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selected modifying factors influence perceptions and ultimately determine if they are associated 
with STD testing behaviors. 
LIKELIHOOD OF ACTION 
Perceived Benefits 
 Perceived benefits refer to the particular course of action that is taken based upon beliefs 
regarding the effectiveness of that action in reducing the perceived threat.  Individuals who 
demonstrate an optimal level of beliefs in susceptibility and severity would not be expected to 
accept any recommended health action unless the action was perceived as potentially beneficial 
(Rosenstock et al., 1994).  The current study assesses whether perceived benefits (expected 
positive effects) affect the behavior of interest, STD testing. 
Perceived Barriers 
 Perceived barriers are the potentially negative aspects of a particular health action which 
may act as obstacles to following a recommended behavior.  Individuals may engage in a cost-
benefit analysis that weighs the effectiveness of a health action against negative perceptions (e.g. 
being too expensive, dangerous, having side effects, unpleasant, inconvenient, time-consuming, 
etc.).  Hence, the perceived threat of disease and the perceptions of benefits (less barriers) 
provide a preferred course of action (Rosenstock et al., 1994).  The current study investigates 
whether perceived barriers to STD testing influenced the study populations’ STD testing 
behaviors. 
Cues to Action 
 Early in the development of the HBM, some formulations of the model included the 
concept of cues that may encourage action.  Although cues may prove to be important when 
assessing health promotion behaviors, its role as an adequate measure for action has not been 
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logically studied (Janz et al., 2002; Rosenstock, 1974).  The current study will not assess whether 
cues to action (e.g. telephone reminders, postcards, etc.) are associated with STD testing 
behaviors. All study participants were encouraged to participate in routine testing and to return 
the home sampling kit.  
 The existing literature provides empirical support for the HBM in explaining health 
prevention behaviors and behaviors in response to symptoms or diagnosed disease (Rosenstock 
et al., 1994).  Janz and Becker (1984) assessed the HBM in 46 prospective and retrospective 
studies of health-related behavior conducted between 1974 and 1984. Some of the preventive 
behaviors included in the review were influenza inoculations, a Tay-Sachs carrier status 
screening program, practice of breast self-examination, and attendance at a high school screening 
program.  Sick-role behavior studies included compliance with anti-hypertensive medications, 
diabetic regimens, and end-stage renal disease regimens.  Summary findings in this review offer 
encouraging support for the HBM in prospective and retrospective studies.  Perceived barriers 
were found to be the strongest predictor of all behaviors while perceived severity was the least 
powerful predictor (Janz & Becker, 1984).  In addition, perceived susceptibility was found to be 
a stronger predictor of preventive health behavior whereas perceived benefits predicted sick-role 
behavior much better (Janz & Becker, 1984; Rosenstock et al., 1994).  This review suggests that 
the HBM components have assisted researchers with explaining preventive and sick-role 
behaviors in an attempt to design programs to promote desired behaviors. 
As a result of studies such as the Janz and Becker (1984) study, the HBM has been used 
more widely to assess the relationship of model components with STD preventive behaviors or 
disease occurrence. In a recent study, Ford and researchers (2004) assessed young adults’ 
perceptions of risk with numerous variables and current chlamydial or gonorrheal infection using 
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Wave 3 of the 2001-2002 National Longitudinal Study of Adolescent Health survey.   This 
survey provides a diverse (68% White, 16% Black, 11% Hispanic, 3% Asian, 1% Native 
American; 50% female), nationally representative sample of over 11,000 sexually experienced 
18 to 26-year-olds who perceived their risk of infection as low (14% of all surveyed). Of 
participants who tested positive for Chlamydia or gonorrhea (approximately 500 participants, 58 
% female; 34% White, 50% Black, 15% Hispanic, and 2% Asian) only 33 percent reported a 
perceived risk of infection (Ford, Jaccard, Millstein, Viadro et al., 2004).  The multivariate 
analyses revealed that perceived risk of infection was associated with being Black or Hispanic, 
using condoms inconsistently or not using them at all, having exchanged money for sex, having 
been tested in the past year but had not received a diagnosis, having received a diagnosis, and 
reporting current symptoms (Ford, Jaccard, Millstein, Bardsley, & Miller, 2004).  The use of the 
HBM construct of perceived risk or susceptibility of infection in this investigation appeared to 
help explain characteristics of the individual who may be at increased risk of infection. 
 Perceived susceptibility has also been studied among several populations to determine its 
relationship with a range of variables. Kershaw and researchers (2004) assessed changes to 
perceived susceptibility, sexual risk behaviors, and attitudes toward condoms among 308 
adolescents (ages 14 to 19, 48% African-American) who had been recently diagnosed with an 
STD. Results indicate that there were no significant changes in perceptions, sexual risk 
behaviors, or attitudes following the diagnosis of an incident STD compared to those with no 
diagnosed incident of STD (T. Kershaw et al., 2004).  Another study conducted by Sydney and 
colleagues (2000) examined racial differences in adolescent’s risk perceptions of major diseases 
(e.g. HIV) and motor vehicle injury.  The findings in this study demonstrate that risk perceptions 
do differ by race, gender, and income.  Girls rated their risk of disease or injury as similar to 
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boys (but are actually at less risk) and Caucasian adolescents rated their risk of disease or injury 
higher than African-Americans for most examples (e.g. car accident, cancer, heart attack, and 
stroke), when the reverse is actually true (Sydney et al., 2000).  Risk for HIV was assessed 
similarly by race and higher for boys.  Mortality data report that these assessments are incorrect 
and that knowledge regarding HIV may impact perceived risk and/or may impact HIV-
preventive behaviors in which individuals engage (Sydney et al., 2000).  Thus, evidence 
demonstrates that individuals misperceive their risk for STDs and HIV that may affect their 
prevention behaviors and be indicators of other background factors (race, gender, knowledge, 
etc.). 
 HBM factors have also been used to predict sexual preventive behaviors in diverse 
populations.  Zak-Place and Stern (2004) tested the utility of the HBM and identified factors of 
the HBM that best predict safe-sex practices among 202 college students in the US (ages 18 to 
22, 82.3% White, 5.7% Black).  Primary results indicated that male students were significantly 
more likely to intend to use condoms in the future while female students were more likely than 
males to report intentions to obtain STD and HIV testing (Zak-Place & Stern, 2004).  Additional 
analyses revealed that neither perceived vulnerability (susceptibility) nor severity of STDs and 
HIV were significant predictors of condom use or intended STD testing (Zak-Place & Stern, 
2004).  A unique finding was that HIV severity was significantly and negatively related to 
intended HIV testing.  Moreover, a coping appraisal variable that was created concerning 
response efficacy (e.g. the higher the perceived benefits, such as early detection and medical 
care, the greater the likelihood that college students intended to get tested) was supported as a 
predictor of both intended STD and HIV testing behavior (Zak-Place & Stern, 2004). So, this 
article was unable to confirm the utility of the HBM to predict sexual preventive behaviors 
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among college students, nevertheless, the HBM can be helpful in creating models that are more 
comprehensive and appropriate for similar populations. 
A similar study conducted by Dorr, Krueckeberg, Strathman, and Wood (1999) explored 
the influence of HBM variables on 111 heterosexual college students’ decision to obtain HIV 
testing (62% women, 93% White).  Findings show that individuals seeking HIV testing 
perceived more benefits of having a test, perceived fewer barriers to getting a test, considered 
future consequences, and engaged in riskier sexual behaviors (Dorr, Krueckeberg, Strathman, & 
Wood, 1999).  Once again, HBM components can be helpful in explaining some testing 
behaviors, but must be expanded for a more in-depth understanding of what impacts these 
behaviors. 
The concept of perceived threat (combination of perceived susceptibility and severity) 
has also been explored.  Crosby and researchers (2001) investigated perceived threat among 522 
high-risk (sexually active in the past 6 months), adolescent African-American females (ages 14 
to 18).  The concept of perceived threat was measured by an adolescents’ worry that they or their 
partner were or would become infected with an STD (Crosby, DiClemente, Wingood, Sionean, 
Harrington, Davies et al., 2001).  Overall, the findings demonstrate that this population of 
adolescent African-American females has low STD worry.  Results revealed that higher levels of 
STD worry (perceived threat of STDs) were associated with a history of an STD, low partner 
communication, and low perceived ability to negotiate condom use with a male partner (Crosby, 
DiClemente, Wingood, Sionean, Harrington, Davies et al., 2001).  So, this study shows that 
components of the Health Belief Model can be combined to measure concepts such as perceived 
threat that are associated with risky behaviors.  
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 Cervical cancer screening behaviors and beliefs have also been investigated using the 
Health Belief Model.  Burak and Meyer (1997) discovered that over 400 women (ages 18 to 23, 
no racial data given) attending a New England college had low perceptions of susceptibility to 
STDs and cervical cancer, but had high perceived severity of STDs and cervical cancer.  
Potential perceived barriers to gynecological screening were pain (36%), embarrassment (62%), 
or belief that gynecological exams are expensive (42%) (Burack & Meyer, 1997).  Overall, HBM 
constructs only explained 15% of the variance in screening behavior, but when two cues to 
action were added to the equation with an intention to have a gynecological exam (i.e. prior 
abnormal Pap and having had an STD), they added little or none to the overall variance (Burack 
& Meyer, 1997).  As a result, HBM constructs provided beneficial information regarding 
gynecological screening, however, the model was not useful in predicting women’s intentions or 
screening behaviors (Burack & Meyer, 1997).  Examining cervical cancer screening in regards to 
STD screening behaviors is similar to STD testing because it includes an invasive technique in 
which women have to endure.   
 In summary, many of the studies reviewed used only specific components of the HBM to 
assess the relationship of HBM factors with disease-preventive behaviors or STD acquisition. To 
my knowledge and from reviewing the literature, there is limited literature that uses HBM 
constructs in predicting STD testing behaviors. The Zak-Place article reported that the utility of 
the HBM was unsupported among a population of college students and that STD testing 
behaviors may reach beyond the standard social-cognitive model.  In contrast, some studies 
demonstrate that HBM components can be helpful in explaining STD or cervical cancer 
screening behaviors.  In general, it appears that the HBM can be used for investigating 
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preventive and sick-role behaviors; yet, further research is warranted to determine methods to 
increase the utility of the model among diverse populations. 
The Applicability of the HBM Among African-American Populations 
 Much of the literature supporting the utility of the HBM has been conducted among 
homogenous populations which do not include African-American or other racial/ethnic 
populations.  Use of the HBM among diverse populations, especially among African-American 
or Hispanic populations, should be of primary concern to public health researchers.  Since the 
racial/ethnic composition of the US is increasingly changing, it is important that research studies 
assess and use the HBM to determine its applicability among underrepresented populations.  
Some of the aforementioned studies have used the HBM among African-American populations  
(Crosby, DiClemente, Wingood, Sionean, Harrington, Davies et al., 2001; Ford, Jaccard, 
Millstein, Bardsley et al., 2004; T. Kershaw et al., 2004; Sydney et al., 2000), however, a closer 
examination of studies that have assessed the utility of the HBM with these populations will be 
beneficial in understanding how to approach further research concerning STD testing behaviors. 
 Some of the areas of recent study regarding use of HBM constructs have focused on 
cancer screening or HIV-risk behaviors among African-American populations.  A study 
conducted by James, Campbell, and Hudson (2002) assessed perceived barriers and benefits 
regarding colorectal cancer screening (CRC) among African-American adults in a church health 
promotion program. Results indicate that perceived barriers were associated with fecal occult 
blood testing (FOBT) while perceived benefits were associated with having had a colonoscopy 
(James, Campbell, & Hudson, 2002).  The findings of this study were interpreted by comparing 
these results to the Janz and Becker (1984) article which found that barriers was the construct 
that was most significantly associated with preventive health behaviors whereas perceived 
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benefits seem to be a more important factor for sick-role behavior (James et al., 2002).  For this 
reason, FOBT in this population appears to be a preventive health behavior where perceived 
barriers played the strongest role in predicting screening behavior and a colonoscopy emerges as 
an early detection or sick-role behavior where perceived benefits play a powerful role (James et 
al., 2002). As a whole, assessing perceived barriers and benefits regarding CRC in this African-
American population proved to be a successful use of the HBM and thus demonstrates that it can 
be appropriately used in this population. 
 Another study performed by Ashing-Giwa (1999) investigated the use of health behavior 
change theories and their socio-cultural relevance for breast cancer screening in African- 
American women.  This article reviewed the HBM and its applicability in this population.  This 
critical review discovered that the constructs of perceived susceptibility, severity, barriers, and 
cues to action are useful in explaining some beneficial influences of breast cancer screening 
behaviors in African American women (Ashing-Giwa, 1999). However, Ashing-Giwa mentions 
that conceptualizations of these constructs should be presented within the proper socio-cultural 
contexts. For instance, perceived barriers should reflect economic and historical obstacles to 
health practices, and perceived susceptibility and severity may not be as salient among African 
Americans where individual risk may not influence behavior change as much as “group 
susceptibility”.  Thus, the HBM can be even more essential to explaining behaviors among 
African-Americans if appropriate socio-cultural contexts and other ethnic experiences are 
applied to the model. 
 Neff and Crawford (1998) took a similar approach to understanding the utility of the 
HBM among racial/ethnic populations, but used this analysis to assess HIV risk behaviors.  It has 
been postulated by others that race/ethnicity is an important factor in the HBM because it 
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represents a value-expectancy theory behavior where rational individuals weigh the costs and 
benefits in an attempt to maximize gain (Neff & Crawford, 1998).  Nonetheless, the HBM 
assumes that all people exist in similar cultures and have similar control of their environments, 
which for HIV behaviors, may or may not be true (Neff & Crawford, 1998).  In understanding 
HIV risk behaviors, one must first understand how the environment shapes choices and 
opportunities as well as how these opportunities, tasks or competencies define an individual’s 
daily existence (Neff & Crawford, 1998).  Thus, Neff and Crawford also agree with Ashing-
Giwa that socio-cultural influences of historical and structural circumstances are not captured in 
the HBM which is the reason for conducting analyses to determine its applicability among 
racial/ethnic populations. 
 As a result, the Neff and Crawford study examined a causal model including perceived 
seriousness, susceptibility and barrier components with HIV risk behaviors among over 1200 
adults (57% female; 32% White, 23% African American, 45% Mexican) who reported drinking 
at least two or three times a month in San Antonio, Texas (Neff & Crawford, 1998).  Results 
indicated that a causal model of the HBM was able to link demographic and perception variables 
with HIV risk behaviors.  On the other hand, ethnic differences in the HBM demonstrated that 
the affects of barriers and susceptibility appear more relevant to Whites and Mexicans than to 
African Americans (Neff & Crawford, 1998).  Limitations of the study did reveal that low levels 
of reliability of the HBM concepts may have played a role in these ethnic differences.  However, 
understanding racial differences in HBM constructs may prove to be beneficial in further 
analyses.  So, the HBM appears to be applicable for diverse populations, nonetheless, improved 
validation of HBM constructs among African-Americans and the inclusion of socio-cultural 
variables in these components is an area that needs to be further explored. 
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Modified Model for the Study
 In 1994, Rosenstock, Strecher, and Becker summarized the HBM components into three 
key categories.  These categories are background, perceptions, and action (Figure 3.2) 
(Rosenstock et al., 1994).  Previous categories of the HBM included individual perceptions, 
modifying factors, and likelihood of action.  These researchers used this latest model framework 
as a more convenient method to explain HIV risk behaviors.  Accordingly, the theoretical 
framework for this study will utilize this modified HBM to explore predictors of STD testing 
behaviors. 
 Selected background variables were chosen for the current study that attempts to examine 
factors that have been previously studied regarding STD-risk behaviors and reflect patient 
characteristics that may influence STD testing behaviors.  Since the main purpose of this study is 
to explore these variables in relationship to two STD testing outcomes, the utility of the HBM 
model will not be tested in this investigation.  Nevertheless, the literature reviewed will be 
helpful in explaining the trends and relationships that will be revealed through data analyses. 
 The theoretical framework that will drive the analyses for this study is modified from the 
Rosenstock article (1994).  The proposed theoretical model (Figure 3.3) includes the following 
predictor variables that will used to assess STD testing behaviors: background factors –socio-
demographic, psychosocial, and health-related factors; perceptions (perceived risk, perceived 
severity, perceived benefits and perceived barriers); and, action (desired health behavior).   
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Figure 3-2          Schematic Design of the Components of the Health Belief Model 
       (Rosenstock, Strecher, & Becker, 1994) 
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Figure 3-3         Modified Schematic Design of the Components of the Health Belief Model 
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A review of the literature suggests that there are gaps in knowledge regarding STD 
testing behaviors of young women. Based on the paucity of research concerning STD testing 
behaviors, the proposed study will be crucial in understanding background and perceptions that 
may influence behavior.  Thus, it is postulated that young women will engage in STD 
preventive-behaviors if:  they regard themselves as susceptible to Chlamydia or gonorrhea, if 
they believe it would have potentially serious consequences, if they believe that STD testing 
would be beneficial in reducing their susceptibility to, or the severity of, STDs and, if they 
believe that the anticipated barriers to (or costs of) taking the action are outweighed by the 
benefits. 
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4. CHAPTER IV 
4.1. METHODOLOGY 
 This chapter describes the methodology used in this study, including the: (1) source of 
data, (2) data collection methods, (3) study variables, (4) data analysis, and, (5) the limitations of 
the study.  This study was approved as “exempt” through the University of Pittsburgh 
Institutional Review Board – IRB # 0506038. 
4.1.1. Data Source 
 This study utilized baseline and follow-up data from the Detection Acceptability 
Intervention for STDs in Young women (DAISY) project.  The Principal Investigator for this 
study is Dr. Roberta B. Ness, Chair of the Department of Epidemiology at the University of 
Pittsburgh Graduate School of Public Health and Professor of Epidemiology at this institution.  
My research preceptor is Dr. Robert Cook who is the Co-Investigator of the DAISY project and 
is an Assistant Professor of Medicine at the University of Pittsburgh School of Medicine.  The 
DAISY project was designed based on results from several preliminary studies regarding STDs 
conducted by Ness and others which found that self-testing for STDs (where a young woman 
collects a test sample herself) could reduce potential barriers to STD testing and thus increase a 
young woman’s willingness to seek Chlamydia testing.    
The DAISY project utilized a randomized, clinical trial study design with two specific 
aims.  The first of which is to: (1) evaluate the effectiveness of home sampling for increasing 
adherence to screening at six month intervals and, (2) to compare the number of lower genital 
tract infections detected in a home screening group and return visit group.  Secondary aims of the 
study include: (1) a comparison of the number of lower genital tract Neisseria gonorrhoeae 
infections detected in a home screening group and return visit group; (2) a comparison of rates of 
treatment for detected chlamydial and gonococcal infections between groups; (3) a comparison 
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between groups, of the proportion of women who had pelvic inflammatory disease (PID) 
diagnosed during the study; (4) a comparison of the prevalence of Chlamydia at the end of 
screening between groups; and, (5) an assessment of attitudes toward STD screening.  Hence, the 
present investigation will be helpful in examining STD testing behaviors in relation to the fifth 
aim. 
The DAISY study has 403 young women as participants in the study.  Approximately 
half (n = 202) of the participants were recruited from one of nine participating clinical settings in 
Pittsburgh, Pennsylvania after being diagnosed with an STD (i.e. Chlamydia, gonorrhea, or 
trichomonas).  The remaining half of the participants (n = 201) were recruited in the community 
via advertisements.  All participants in the DAISY project were between 14 and 29 years of age.  
A waiver of parental consent for participants aged 14 to 17 years old was granted. 
Study Population 
 The study population for this exploratory research consists of 171 young women in the 
DAISY project who has completed their two year participation in the study. Data from baseline, 
follow-up, and chart abstractions is used for the data analyses.  Although the original sample of 
DAISY participants is 403 young women, this study focuses on those participants who have 
completely finished the two-year study period.  
Recruitment 
 Women were recruited for the DAISY project either through provider referral, posted 
advertisements in participating clinics or in the community, or by referrals from friends.  Women 
could answer advertisements by calling a toll-free number to learn about the study or contact 
study recruiters if referred by providers or clinics.  Eligibility criteria included: females ages 14 
to 29 years old, being sexually active, and willing to participate.  Additional requirements 
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included meeting at least 3 of 5 criteria known to increase the risk of acquiring an STD.  These 
criteria are: being < 20-years-old, living in a high-risk neighborhood, Black race/ethnicity, 
participation in regular douching, and having had > 1 sexual partner.  High-risk neighborhoods 
were identified as areas with high rates of Chlamydia and gonorrhea as determined by statistics 
of the Allegheny County Health Department in Pittsburgh, PA.  Women were excluded from the 
study if they are: (a) pregnant (pregnant women have different screening recommendations); (b) 
homeless (unable to obtain a home sampling kit); (c) married (married women do not have a high 
risk of acquiring an STD); or (d) currently being examined for gynecological infections more 
than once a year (may not benefit from home sampling and not generalizable to study outcomes).  
 If a young woman met the inclusion criteria, she was consented and enrolled in the study.  
These women were also sent additional brochures to give to friends.  If friends enrolled in the 
study, participants received $10 for every friend enrolled.  After enrollment, women completed a 
baseline instrument.  All participants provided written informed consent as approved through the 
Institutional Review Board at the University of Pittsburgh and participating hospital-based 
clinics. 
4.1.2. Data Collection Methods 
 Female interviewers conducted in-person or telephone interviews using a standard 
consent procedure and baseline questionnaire.  The baseline survey took approximately 15 to 20 
minutes to complete.  Information on the baseline questionnaire captures 12 categories: (1) 
demographics; (2) general health; (3) stress; (4) mood (depression); (5) social support; (6) abuse; 
(7) alcohol use; (8) substance use; (9) history of STDs; (10) attitudes toward screening; (11) 
health locus of control; and (12) sexual behavior. In addition to administering the baseline 
survey, participants recruited from the community have a baseline Chlamydia and gonorrhea test. 
 72
Women who completed a telephone interview were mailed their consent forms and 
instructed to return it to research assistants.  These participants also completed a vaginal swab 
self test for a baseline STD test.  This test could have either been mailed to the participant or 
picked up at a participating clinic.  Participants also chose a participating clinic to receive 
follow-up care. After the consent form and baseline questionnaire were completed, the 
participant was assigned a clinic identifier and this information was stored in a locked cabinet. 
Next, the participant underwent the intervention/control randomization process. 
A schematic diagram of data collection procedures for the overall DAISY study is 
provided. (Figure 4.1). 
Baseline Questionnaire 
The baseline questionnaire for the DAISY project was developed by Cook and others 
based on preliminary studies conducted concerning alcohol use and STDs.  The surveys used for 
these studies were administered to college students in Pittsburgh, PA (Barth et al., 2002).  Thus, 
the survey has been pilot tested numerous times and used in populations of college women.  
Specific categories of the baseline survey will be discussed later. 
Intervention 
 After completion of the consent process and baseline survey, participants were 
randomized to either the home testing group or return visit group. During the baseline interview, 
women were told to expect 6, 12, and 18 month reminders to return to a clinic for screening or 
that they will receive a home sampling kit (based on group assignment).   
 For the clinic testing group, women received a reminder, enclosed in a sealed envelope, 
to return for STD testing.  During the return visit, a standardized protocol was followed where 
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women underwent a pelvic examination with a vaginal swab specimen collected that was tested 
for Chlamydia and gonorrhea.  Regular clinical care was also provided, if needed. 
 For the home sampling group, women either had the Chlamydia/gonorrhea kit mailed to 
their home or arranged to pick it up.  The home testing kit contained a swab (similar to a Q-tip), 
a small vial of media, instructions on how to collect the sample, and a mailing tube.  Instructions 
told participants to insert the swab about one inch into the vagina for approximately 15 seconds.  
Then they were instructed to remove it, place it in the vial, seal it, and place it in the postage-paid 
mailing tube. 
Biological STD testing Data Collection  
Collection of swab samples by the provider and by home testing participants went 
through a strand displacement amplification assay.  This assay (BDPROBE TecJ, Becton 
Dickinson Sparks, MD) was used to detect Chlamydia and gonorrhea from the genital 
specimens.  Swab samples can be stored at 2 to 30 degrees Celsius for up to 14 days with no loss 
of test sensitivity.  The clinical specimens were express mailed to the Infectious Disease 
Laboratory at Magee-Womens Research Institute in Pittsburgh, PA for analysis. 
 All laboratory results were available in 48 hours.  The research assistant to the DAISY 
study contacted participants with a positive test result.  Then, the research assistant either called 
in an antibiotic treatment at a local pharmacy for the participant or had them return to a clinic for 
free antibiotic treatment (based on insurance status and patient preference).  Women who could 
not be contacted about their positive test results were sent a certified letter to return for 
treatment.  Treatment for Chlamydia included doxycycline and treatment for gonorrhea was 
ceftriaxone which are recommended drug regimens by the 1998 CDC guidelines (CDC, 1998).  
In addition, protocols for disease reporting to the health department were also followed. 
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Figure 4-1 Schematic Diagram of Data Collection Procedures 
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One year and Two-year Follow-up Data 
 One year after enrollment, participants were contacted to answer a brief follow-up 
questionnaire.  This questionnaire inquired about STD-related medical history, number of pelvic 
exams received in the past year, and pregnancy information. Participants were paid $10 for 
return of this survey.  In addition, contact information was obtained again just in case the 
participant has changed her address.  
 Two years after enrollment, participants were contacted regardless of how many 
screening tests they had completed.  At this time, all participants were mailed or picked up a 
home sampling test to be mailed for STD analysis.  The purpose of the final test was to compare 
the prevalence of Chlamydia in the intervention group versus the control group. 
 A final interview was also completed over the telephone.  This interview: (1) assessed the 
evidence of other STDs or PID diagnoses; (2) repeated alcohol and substance use questions; (3) 
assess clinic use in the past two years of the study; (4) enumerated pregnancies; (5) asked about 
pap tests and breast exams in the past year; (6) assessed STD-preventive behaviors; and (7) 
assessed the opinions of the home testing group.  Women who saw a provider for a health-related 
complaint or exam were asked to provide release of information so that medical records could be 
reviewed. 
 Medical chart abstractions collected information on: (1) reason for office visit; (2) patient 
symptoms; (3) physical exam results; (4) laboratory testing – STDs, pap, vaginal wet mount; (5) 
pharmacy report; (6) possible ultrasound results; (7) urinalysis; and (8) pregnancy information. 
 To ensure completion of the second year STD test, a second mailing occurred along with 
a $2 incentive to return the test. In addition, follow-up interviews for the last interview occurred 
as well as contacting friends and relatives to locate the participant. 
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4.1.3. Study Variables 
 Background variables and perceptions (predictor) and outcome variables for the current 
study were either extracted or developed from the baseline DAISY survey.  Preliminary analyses 
assisted with identifying predictor variables for inclusion in the larger analysis. Moreover, a set 
of factor analyses were completed to create perception variables that were more parsimonious 
with their meanings.  Outcome variables were selected based on suggestions from the literature 
for further research and the ability to complete some of the secondary aims of the DAISY 
project.  The operational definitions of predictor variables are consistent with definitions given 
for similar variables in the literature reviewed.  The measurement of independent and dependent 
variables will be explained below. 
Predictor Variables 
 AGE 
 Age was assessed by asking participants their date of birth. 
 RACE 
The following questionnaire item was used to assess the race or ethnic group of the 
participant: “What race or ethnic group do you consider yourself a part of?  Responses offered 
were Black or African-American, White, Hispanic, Asian/Pacific Islander, Native 
American/Alaskan Native, and Other (specify). 
EDUCATION  
The following questionnaire item was used to assess the educational level of the 
participant: “What was the highest grade of school you completed?  Responses to this question 
were none, some grade school (1-6yrs), some junior high (7-9 yrs), some high school (10-11 
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yrs), high school graduate/GED, post high school training or technical school, some 
college/associate degree, and college graduate/post-graduate. 
ATTEND RELIGIOUS SERVICES OR NOT 
The following questionnaire item was used to assess whether or not participants attend 
church services: “Do you go to church or attend a religious service at least once a week on most 
weeks?”  Yes (1) or no (0) responses were given. 
AGE OF FIRST SEXUAL INTERCOURSE 
 The following questionnaire item was used to determine the age of participants at coital 
debut: “How old were you when you had sexual intercourse for the first time?”  Respondents 
gave the age for this question. 
STRESS 
 Stress was assessed using the perceived stress scale (PSS) which is a four-item scale that 
measures the degree to which situations in one’s life are appraised as stressful during the past 
month (S. Cohen, Kamarack, & Mermelstein, 1983).  An example questionnaire item used was, 
“During the past month, how often did you feel that you were unable to control the important 
things in your life?”  The responses for this item ranged from 0 (never) to 4 (very often).   
MOOD  
 The mood of study participants was assessed using the Center for Epidemiologic Studies 
Depression Scale (CES-D).  This short self-report scale (20 items) was designed to measure 
current level of depressive symptomatology in the general population (Radloff, 1977).  An 
example questionnaire item used was, “You were bothered by things that usually don’t bother 
you.”  The responses for this item ranged from 0 (rarely or none of the time – less than one day) 
to 3 (most or all of the time – 5 to 7 days).  
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SOCIAL SUPPORT 
 Perceived social support was assessed using 5 items regarding how often participants 
have family or friend support for various situations (Ren, Skinner, Lee, & Lewis, 1999).  An 
example questionnaire item used was, “How often do you have a family member or friend that 
you can confide in or talk to about your problems?”  The responses for this item ranged from 1 
(none of the time) to 5 (all of the time).   
HEALTH LOCUS OF CONTROL 
 The health locus of control for study participants was determined by 9 items modified by 
Kelly and researchers (1990) which reflect three dimensions of the original Health Locus of 
Control Scale.  The three dimensions are: internal control (sample item: “If you take the right 
steps, you can avoid getting a sexually transmitted disease”), chance or luck – external control 
(sample item: “If you get a sexually transmitted disease, it’s a matter of fate or bad luck”), and 
powerful others – external control (sample item: “Other people play a big part in whether you get 
a sexually transmitted disease”) (Kelly et al., 1990).  The responses for these items ranged from 
1 (strongly disagree) to 5 (strongly agree).   
PAST STD HISTORY 
 A previous STD history was determined by asking participants, “Has a doctor or health 
worker ever told you that you had: Chlamydia, gonorrhea, PID, bacteria vaginosis (BV or 
gardnerella), trichomonas (or trich), genital warts (human papilloma virus or HPV), genital 
herpes, HIV or AIDS, syphilis (or “bad blood”), vaginal yeast infections, or crabs (pubic lice)?”   
Yes (1) or no (0) responses were given for this item.  
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 PAST HISTORY OF SEXUAL ABUSE 
 The following questionnaire item was used to determine whether participants had a 
history of sexual abuse: “During your childhood or adolescence, did your parent or person who 
raised you or anyone else you lived with ever force you to have sex against your will?  By sex, I 
mean touching your sexual parts, you touching their sexual parts, or sexual intercourse?  Yes (1) 
or no (0) responses were given for this item.  
 CURRENT ANTIBIOTIC USE 
 The current use of antibiotics was assessed by asking participants, “Are you currently 
taking or did you take antibiotics for your most recent (Chlamydia or gonorrhea) infection?”  
Yes (1) or no (0) responses were given for this item. 
SYMPTOMS OF AN STD 
The following questionnaire item was used to determine whether participants had 
symptoms of an STD at baseline: “When you went to the clinic on that visit, did you have 
symptoms of an infection such as vaginal itching, burning, or abnormal discharge or bleeding?” 
Yes (1) and no (0) responses were given for this item. 
 CONDOM PROBLEMS 
 The following questionnaire item was used to determine whether participants had any 
condom problems in the past 6 months: “If YES to condoms, in the past six months, have you 
had any of the following problems when using condoms?”  The responses offered were: the 
condom broke or ripped (1); the condom slipped or fell off (2); the condom was put on inside out 
and flipped over (3); the condom was put on halfway through sex, after the penis had been in the 
vagina (4); the condom was removed halfway through sex (5); tried to use a condom, but 
couldn’t put it on (6); other condom use problem (7); none of the above (8).  
 80
DOUCHING BEHAVIOR 
The following questionnaire item was used to determine douching behaviors of 
participants: “Do you douche at least once a month (that is, squirt a liquid into your vagina)?” 
Yes (1) and no (0) responses were given for this item. 
 NUMBER OF SEXUAL PARTNERS (IN THE PAST YEAR) 
 The number of sexual partners in the past year for each participant was assessed by 
asking, “During the past year, with how many different partners did you have sexual 
intercourse?”  A number was given for this response. 
 ALCOHOL USE 
 The use of alcohol in the past year was assessed by asking, “How often do you have a 
drink containing alcohol?”  Responses given for this item were: (1) monthly or less; (2) two to 
four times a month; (3) two or three times a week; (4) four or more times a week. 
 CIGARETTE USE 
 The following questionnaire item was used to determine whether participants smoked 
cigarettes or not: “Do you currently smoke cigarettes?”  Yes (1) or no (0) responses were given 
for this item. 
 MARIJUANA USE 
 The following questionnaire item was used to determine whether participants ever used 
marijuana or not and the frequency of their use: “If you have ever used marijuana or pot, how 
many times in the past month have you used it?”  Numerical responses were given for this item. 
Perceptions 
 The perceptions regarding STDs were assessed using 4 components of the HBM.  These 
items were originally developed by researchers in the DAISY project.  However, the original 
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items were used in a factor analysis model to make these questionnaire items fit more 
parsimoniously with the constructs of the HBM. The procedures and results of the factor 
analyses and other reliability tests completed are discussed later in the methodology section. 
PERCEIVED SUSCEPTIBILITY 
 Perceived susceptibility was originally assessed by asking respondents a set of 5 
questions. Factor analyses determined that 2 items measured perceived risk of an STD as more 
related to one another.  These items are: “You can generally tell if your sexual partner has an 
STD” and “You can tell if you have an STD”.  The responses for these items ranged from 1 
(strongly disagree) to 6 (strongly agree).   
PERCEIVED SEVERITY 
Perceived severity of an STD was initially assessed by 2 items.  Factor analyses 
determined that one of these items seemed to measure perceived severity of STD the best.   This 
questionnaire item was: “Getting Chlamydia and gonorrhea infection might make you unable to 
get pregnant”. The responses for these items ranged from 1 (strongly disagree) to 6 (strongly 
agree).   
PERCEIVED BENEFITS  
Perceived benefits of STD testing was determined by asking respondents the following 
questionnaire items, “You would want to know if you had a STD in the future”; “Treating a STD 
early, instead of waiting, is more likely to prevent future problems”; “You would want to be 
tested in 6 months to be sure that nothing was wrong”; and “It is important for you to be tested so 
you won’t infect someone else”.  The responses for these items ranged from 1 (strongly disagree) 
to 6 (strongly agree).   
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PERCEIVED BARRIERS (HARMS) 
Perceived barriers to STD testing were originally assessed by asking respondents 6 
items.  However, 8 additional questions were added regarding barriers to STD testing procedures 
and clinical factors. Factor analyses were performed on all these items and 2 types of barriers 
emerged from this analysis. Individual barriers to STD testing are determined by asking 
participants the following 8 questionnaire items: “People might think you were a bad person if 
they knew you were getting tested for a STD”; “Getting checked for a STD by a pelvic exam is 
embarrassing”; “You would feel stupid if you caught a STD”; “You would worry that people 
who live with you would find out you had a STD”; “You are afraid of pain during a pelvic 
exam”; “You don’t like to have someone examine your vagina, genitals, or private parts”; “Most 
people think STDs are disgusting”; and “Most people look down on someone with a STD”.  
These last two items are considered to measure stigma associated with individual perceptions of 
barriers to STD testing. 
 Test procedure barriers were assessed by asking respondents 3 items: “You would be 
more likely to get a STD test if you could do it yourself”; “It is hard to find time to get checked 
for a STD”; and “You worry that someone you know will see you in the waiting room when 
getting a STD test”.   The responses for both perceived barrier measures ranged from 1 (strongly 
disagree) to 6 (strongly agree).   
Outcome Variable 
 TOTAL NUMBER OF STD TESTS COMPLETED 
 The outcome variable total number of STD test completed was assessed by participants’ 
STD testing behaviors throughout the DAISY project.  These behaviors were enumerated from 
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the return of home sampling kits (if the participant is in the intervention group), follow-up 
surveys and chart abstraction data.  
4.1.4. Data Analysis 
 The following section discusses the statistical procedures used in the current study.  All 
analyses were performed using Statistical Program for the Social Sciences (SPSS, version 12.0 
for Windows) and STATA (Intercooled versions 8.0 and 9.0 for Windows).  
Development of Measures 
 A discussion regarding the rationale for the use of specific measures and the development 
of perception variables is warranted in this study.  Due to the fact that this study is exploratory, 
many of the measures were created to fit the data well and appropriately measure intended 
domains. Thus, the following is a description of these measures and their operationalization for 
this study. 
 PSYCHOSOCIAL VARIABLES 
 The psychosocial variables utilized in this study (stress, depression, social support, and 
health locus of control) are all valid and reliable measures that have been used in published 
studies in peer-reviewed journals.  The cognitive variable of stress is being measured using the 
perceived stress scale that was originally developed by researcher, Sheldon Cohen, in the 1970s.  
Since then, the perceived stress scale has been used in many academic disciplines, including 
areas that explain health behavior. The original perceived stress scale included 14 items; 
however, this study will use the validated 4-item scale (S. Cohen & Willamson, 1988).  Prior 
studies demonstrate that this 4-item scale has adequate reliability to be a useful measure of 
perceived stress for situations requiring a brief scale.  The alpha reliability coefficient that is seen 
for this scale is 0.60.  Higher scores of stress indicate higher perceived stress.  
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 The scale used to measure depression is the CES-D Scale which is a widely used 
depression scale developed by researchers at the National Institute of Mental Health.  This scale 
consists of 20 items and has reliability and validity among adult and adolescent populations.  
Internal consistency reliability is generally in the 0.80 to 0.90 range (Radloff, 1991). Higher 
scores indicate higher levels of depression. 
 Perceived social support was measured on 5-items and determined how often, in general, 
the participant perceived that she had support from her family or friends.  A prior study used this 
scale in a representative sample of citizens in the US and found the reliability coefficient to be 
0.71 (Ren et al., 1999).  Higher scores indicate more perceived social support. 
 The last psychosocial variable being measured is health locus of control.  The original 
health locus of control scale was developed by Wallston and researchers in the 1970s and was a 
unidimensional scale (Wallston, Wallston, & DeVellis, 1978).  The scale used in this study was 
multi-dimensional and adapted from a nine item scale used to investigate HIV counseling effects 
(Ickovics et al., 1998).  The three dimensions of the scale are internal health locus of control (the 
individual having control of whether they acquire an STD or not), powerful others locus of 
control (whether or not the individual gets an STD is determined by other people), and chance 
health locus of control (if the individual gets an STD, it is a matter of fate or bad luck).  Previous 
studies have used the multidimensional health locus of control scale in different populations. 
Within the Ickovics study, this variable had a reliability coefficient (Cronbach’s alpha) of 0.55 
(Ickovics et al., 1998). 
 PERCEPTIONS 
 An exploratory factor analysis was conducted on the 28 questionnaire items that assessed 
various perceptions regarding STDs and STD testing. The purpose of exploratory factor analysis 
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is to investigate the relationships among perception variables and to create more parsimonious 
and reliable measures for these domains (Thompson, 2004). More specifically, exploratory factor 
analysis computes a matrix of coefficients where the coefficients refer to the correlations 
between factors and variables (Kim & Mueller, 1978).  Factors can be hypothesized, 
unmeasured, or underlying variables which are presumed to be the sources of the observed 
variables (Kim & Mueller, 1978). For this study, the factors will be the four main constructs of 
the HBM (perceived risk, severity, benefits, and barriers) which will be correlated with the 
original 28 variables.  So, this statistical process will be helpful to determine the validity of the 
original items to correctly measure the HBM components. In addition, a reliability coefficient 
(Cronbach’s alpha) was computed to determine the degree of consistency in which the 
instrument measures the HBM constructs and also validates the results of the factor analyses. 
The main assumption for factor analysis is that relationships between variables can be 
represented by a correlation coefficient.  This is true for the current exploratory study. 
In an exploratory factor analysis, usually the three main steps are: (1) preparing an 
appropriate covariance matrix; (2) extraction of initial factors; and (3) rotation to a terminal 
solution (Kim & Mueller, 1978).  To address steps one and two for this study, the original 28 
items used to measure components of the HBM were entered into an exploratory factor analysis 
application using an extraction method called the principal components analysis. This analysis 
examines the interdependence among the variables and hypothesizes the minimum number of 
common factors that would be needed to reproduce the observed factors.  In addition, this 
analysis is used to account for as much variance as possible in the data by using eigenvalues (a 
mathematical property of a matrix) and cumulative percentages.  
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Since the purpose of this factor analysis was to determine which questionnaire items fit 
the four components of the HBM, the initial principal components analysis extracted 5 
components for explanation and eliminated factors in the component/covariance matrix with 
correlation values less than 0.30 – criteria set to exclude relationships that were not strong  (See 
Figure 4.2).  A table showing the variance of these components to the data was also given (See 
Figure 4.3).  
Based on the most widely used criterion of determining the number of components that 
are important for extracting in a principal component analysis (eigenvalues greater than 1 in the 
table variance – Figure 4.3), this result revealed that there were 10 components that were 
significant concerning this analysis and accounted for 58% of the total variance. Yet, the 
extraction of 5 components explained approximately 37% of the total variance in the data. To 
validate the decision to extract only 5 components, a graphical test called a scree plot test was 
also used to determine the number of component factors that should be extracted to create more 
parsimonious measures – point where eigenvalues begin to level off forming a straight line (See 
Figure 4.4).  This test demonstrated that no more than 5 components should be extracted. 
To address step three, another principal component analysis was employed that used 
varimax rotation to determine a terminal solution to this application (Figure 4.5). Varimax 
rotation simplifies the factor structure by maximizing the variance of a column of the pattern 
matrix (Kim & Mueller, 1978).  After completing this 5 component analysis, another analysis 
was employed that removed 2 items which did not fit any of the 5 components extracted (“Catch 
STD year” and “Most people think STDs are no big deal”).  A final component matrix for this 
analysis can be seen in Figure 4.6.  The data were reduced because these 2 items did not appear 
to measure something within the 5 components. 
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  Component Matrix(a) 
 
Component 
  1 2 3 4 5 
Catch STD year      -.356 
STDs symptoms   .596     
Tell partner has STD   .617 -.385    
Tell if you have STD   .793     
No STD if use condom   .386   .455 
STDs aren't serious    -.387    
Want to know if had STD    .471 .423   
Treating STD helps 
prevent future problems    .390 .336   
Tested again in 6 months 
  .339 .406    
Test to not infect others    .569    
Bad for getting tested .553      
Pelvic exams embarassing 
.577      
Stupid if caught STD .415    .369 
Housemates find out .560      
Pelvic exam pain .391      
Partner would blame you .341    -.324 
Don't like exams .579      
More likely test if done by 
self .395  .352 -.459   
Hard to find time .485   -.429   
Clinics confidential      .383 
Getting to clinic is easy     .313   
Use home test   .347 .385 -.528   
Be seen in waiting room .601      
Don't like to touch self in 
genital area .320   .359   
Most people think STDs 
are no big deal        
Most people think STDs 
are disgusting .320      
Most people look down on 
someone with STD .451      
Extraction Method: Principal Component Analysis. 
a  5 components extracted. 
 
 
 
Figure 4-2  Original Principal Components Analysis 
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 Total Variance Explained 
 
Initial Eigenvalues Extraction Sums of Squared Loadings 
Component Total 
% of 
Variance Cumulative % Total 
% of 
Variance Cumulative % 
1 3.118 11.550 11.550 3.118 11.550 11.550 
2 2.046 7.578 19.127 2.046 7.578 19.127 
3 1.858 6.882 26.010 1.858 6.882 26.010 
4 1.567 5.803 31.812 1.567 5.803 31.812 
5 1.400 5.184 36.996 1.400 5.184 36.996 
6 1.306 4.835 41.832    
7 1.218 4.510 46.342    
8 1.131 4.189 50.531    
9 1.084 4.016 54.547    
10 1.024 3.791 58.338    
11 .975 3.611 61.949    
12 .911 3.374 65.322    
13 .862 3.192 68.514    
14 .826 3.060 71.574    
15 .794 2.940 74.514    
16 .774 2.868 77.382    
17 .734 2.718 80.100    
18 .696 2.576 82.676    
19 .678 2.512 85.188    
20 .619 2.291 87.479    
21 .614 2.274 89.754    
22 .537 1.989 91.742    
23 .504 1.865 93.607    
24 .489 1.812 95.419    
25 .468 1.733 97.152    
26 .410 1.520 98.671    
27 .359 1.329 100.000    
Extraction Method: Principal Component Analysis. 
 
 
Figure 4-3    Component Variance 
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The next step in the factor analysis application was to decide which components 
measured which construct of the HBM using the final component matrix (Figure 4.6).  This 
decision was made based on the questionnaire item and high factor loadings on the component 
matrix.  For component 1, many of the factor loadings weighted most heavily on questionnaire 
items associated with perceived barriers of testing (individual barriers of STD testing). When 
these items were placed in a reliability analysis, 10 major items emerged.  An additional item 
measuring the possible stigma of getting an STD was also included in this analysis since the 
other stigma item loaded on this component. Overall, the reliability analysis for these 11 items 
yielded a Cronbach’s alpha of 0.687 for individual barriers.  
For component 2, the majority of the factor loadings were weighted on questionnaire 
items associated with perceived susceptibility of STDs.  Although an original 5 items were used 
for this item, the factor and reliability analysis confirms that the 2 strongest items for measuring  
this variable was: “You can generally tell if your sexual partner has a STD” and “You can tell if 
you have a STD”.  This variable has been defined as perceived risk for the purposes of this 
exploratory study.  A Cronbach’s alpha of 0.674 was yielded for these 2 items. 
For component 3, many of the factor loadings were on questionnaire items that assessed 
attitudes regarding STD testing.  These items were then used in a reliability analysis.  This 
analysis resulted in 4 items that appeared to best measure test/clinic barriers to STDs. The 
strongest.  The reliability coefficient is 0.563 for these test/clinic barriers.  These items are: “You 
would be more likely to get an STD test if test done by self”; “It is hard to find time to get 
checked for an STD”; “You would consider using an STD at home if one was available”; and 
“You worry that someone you know will see you in the waiting room when getting an STD test”.   
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Figure 4-4     Scree Plot of Eigenvalues for the Original Principal Components Analysis 
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Rotated Component Matrix a
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Component
Extraction Method: Principal Component Analysis. 
Rotation Method: Varimax with Kaiser Normalization.
Rotation converged in 6 iterations.a. 
 
Figure 4-5  Principal Component Analysis after Varimax Rotation 
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Extraction Method: Principal Component Analysis. 
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Rotation converged in 6 iterations.a. 
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Figure 4-6    Principal Component Analysis for 5 Components – Removal of 2 Variables 
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For component 4, most of the factor loadings were on questionnaire items that examined 
perceived benefits of STD testing.  All four of these items were used to measure perceived 
benefits and received a reliability coefficient (Cronbach’s alpha) of 0.508. These items are: “You 
would want to know if you had an STD in the future”; “Treating an STD early, instead of 
waiting, is more likely to prevent future problems”; “You would want to be tested in 6 months to 
be sure that nothing was wrong”; and “It is important for you to be tested so you won’t infect 
someone else”. 
Lastly, for component 5, many of the loadings did not appear to measure any specific 
construct of the HBM. Yet, the construct of perceived severity had not yet been determined.  So, 
the initial 2 items used to measure perceived severity were examined.  Decisions regarding the 
applicability of each item to the study and the weak loading for one of the severity items in 
another component, led to the creation of 1 item for perceived severity. Thus, perceived severity 
was measured using the question: “Getting a Chlamydia or gonorrhea infection might make you 
unable to get pregnant”.    
Components 1 and 3 were later combined to give a more complete measure of barriers to 
STD testing. Since they both had one questionnaire item in common, “You worry that someone 
you know will see you in the waiting room when getting an STD test”, this created a perceived 
barriers measure with 13 items which yielded a Cronbach’s alpha of 0.702.  This was helpful to 
improve the reliability of the barriers construct since component 3 alone had a low reliability 
coefficient.  The remaining 12 items for this barriers to STD testing are: “People might think you 
were a bad person if they knew you were getting tested for a STD”; “Getting checked for an STD 
by a pelvic exam is embarrassing”; “You worry that people who live with you would find out if 
you had an STD”; “You are afraid of pain during a pelvic exam”; “You don’t like to have 
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someone examine your vagina, genitals, or private parts”; You would feel stupid if you caught an 
STD”; Most people think STDs are disgusting”; “Most people look down on someone with an 
STD”; “You would be more likely to get an STD test if you could do it yourself”; and “It is hard 
to find time to get checked for an STD”. 
OUTCOME VARIABLES 
The outcome variable, “total number of STD tests completed”, was used as a continuous 
variable in the analyses. 
Analyses for Addressing Research Questions 
Several analyses were conducted in this exploratory study and were approached from 
different statistical levels. The goal of doing this was to have a better understanding of all 
research variables for this study. The first type of analysis that was performed to address the 
proposed research questions was descriptive statistics.  This included calculating means/medians, 
standard deviations, frequencies, and percentages. This information is essential in summarizing 
the distribution of the variables of interest in this study. In addition, univariate regression 
analyses were employed to determine each variable’s association with perceptions or total 
number of STD tests completed. 
 The last analysis was a multivariate analysis. This analysis was used to determine which 
background and perception variables are associated with the outcome of interest.  A stepwise 
multiple linear regression analysis was used.  Linear regression is a statistical method that can be 
used to study the relationship of a continuous outcome variable with one or more predictor 
variables that may be either continuous or categorical variable(s) (Rosner, 2000). Additionally, 
the type of stepwise regression analysis used for this study was backwards selection which starts 
with all variables in the model and then removes them step by step according to their 
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significance to the outcome variable (Total number of STD tests completed). This model 
building strategy yields the best model that characterizes what impacts the outcome variable.  
Regression coefficients were used to interpret the results of this analysis.   
 For most analyses, p-values were computed.  Since this was an exploratory study, p-
values less than 0.10 were used as the cut-off for significance.  This cut-off is less conservative 
than the usual cut-off of 0.05.  However, due to the nature of the variables used and this being a 
secondary analysis, a less conservative significance level may be helpful in discovering factors 
which may reveal certain trends in the outcome of interest. 
4.1.5. Limitations of the Study     
 There are several limitations to the research.  First, this investigation is restricted to use 
of specific variables and certain analyses because this is a secondary data analysis.  Development 
of measures and other issues related to types of research questions are maintained within the 
limits of the available data.  Hence, the goals of this research are influenced by what data can be 
extracted from the baseline survey and other subsequent data collected as part of the DAISY 
project.     
Second, the proposed exploratory study is a longitudinal study that is using cross-
sectional data from which to draw conclusions.  This means that data was collected at one point 
in time and thus direction of causation is not understood and must be interpreted from theoretical 
assumptions.  Although using cross-sectional data to characterize longitudinal data limits the 
interpretation of the analyses, this study can still offer explanations for the relationships that exist 
among the baseline and outcome variables. 
 96
Third, the sample chosen for this study is mostly high-risk, young African-American and 
White women with riskier sexual behaviors than the general population.  So, the results may not 
be generalizable to women in the general population.  
 Fourth, the baseline questionnaire that was used to assess the STD behaviors of young 
women in this study may not be adequate for this population.  The questionnaire was initially 
pilot tested among young college aged women who are significantly different from the clinic and 
community sample used for this study. So, the reliability and validity of this questionnaire to 
appropriately assess many factors related to the STD testing behaviors of the study population 
may be questionable. Yet, since this is an exploratory study, conclusions given may demonstrate 
other avenues to improve questionnaire reliability and validity for similar clinic and community 
populations such as the participants in the overall DAISY project. 
Fifth, there are two background variables which may not have appropriately assessed 
what they intended to measure. Age at first intercourse asked at what age the participant had sex 
for the first time, but whether it was forced or voluntary cannot be determined. A past history of 
sexual abuse asked respondents about persons who the participant knew or lived with who may 
have forced them to have sex, but the question did not include persons that the participant may 
not know or did not live with who might have raped them.  This issue is another limitation of 
conducting a secondary analysis and will limit conclusions about the relationships of these 
variables in the data. 
Sixth, the past STD history measure and number of sexual partner(s) measure are self-
reported variables which may be prone to measurement error or underreporting.  Self-report data 
are usually subjected to underreporting of unwanted diseases or infections and even more so for 
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asymptomatic conditions such as acquisition of Chlamydia and gonorrhea. Young women may 
not know they were infected and thus may not have sought testing in the past for diagnosis. 
Additionally, women may not remember the correct number of sexual partners they had in the 
past year or may underreport because of wanting to give socially acceptable answers.  
 Seventh, other socio-demographic variables such as income and educational level may 
not be appropriate for this study. Younger women in this study may not know their household 
income and may not have answered this question or guessed.  This can result in measurement 
error concerning income.  In addition, comparing the educational level of adolescents with young 
adults may only reveal cognitive or behavioral differences based on age and not necessarily due 
to lack of education.  The lower age groups in this study have not completed high school only 
because they are not old enough.  Thus, more measurement error may occur because of this 
interpretation. 
 Eighth, this study is an exploratory study and will not be used to test the utility of the 
Health Belief Model.  So, many of the low reliability coefficient levels (Cronbach’s alpha < 
0.70) reported from the perception variables created using the factor analysis are preliminary and 
adequate for such an investigation (perceived susceptibility alpha = 0.674, perceived barriers = 
0.702, and perceived benefits = 0.508). For social science research, the most widely accepted 
cut-off is an alpha of 0.70 or higher. Some researchers may be as lenient as 0.60.  Higher values 
of this reliability coefficient (Cronbach’s alpha) indicate questionnaire items that demonstrate a 
stronger reliability to measure what the researcher intended to measure. While, lower scores of 
reliability mean that the items may not be the most optimal to use in measuring the intended 
construct.  Thus, perceived benefits created through this factor analysis is the best measure 
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possible based upon the items provided in the baseline survey, but they may not be the best 
questionnaire items that should have been created to measure this construct of the HBM. 
 Lastly, due to the small number of women included in the study sample, there may not be 
enough power to detect differences among groups and may limit the types of analyses that can be 
performed on the data (i.e. racial differences, etc.).  
4.1.6.  Delimitations 
 Many of the limitations for this study cannot be addressed due to the exploratory nature 
of this investigation, however, preliminary analyses (i.e. factor analyses, univariate regression 
analysis – to reduce number of background variables, etc.) aided in overcoming some errors in 
measurement. Although secondary and cross-sectional data will limit the types of analyses and 
conclusions made in this study, the results will give some insight into the relationships among 
these variables.  This can also assist the generation of hypotheses for further research in this area. 
The use of high-risk groups for this study is warranted because these are individuals who 
are at highest risk for STD acquisition.  So, results may not be generalizable to the general 
population, but will be helpful regarding participation in STD screening programs for high-risk 
groups. In addition, data can assist with improving health system factors that encourage 
participation in STD testing programs and provide a non-threatening test environment. 
The inappropriate questionnaire items used to measure age at first intercourse and past 
history of sexual abuse cannot be addressed because this is a secondary data analysis.  This will 
limit some of the conclusions about the data.  Further exploration of this issue can be completed 
in a follow-up qualitative study that asks more in-depth questions regarding the sexual history of 
DAISY participants. 
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Preliminary analyses conducted influenced the variables that will be ultimately used in 
the final analyses. So, issues concerning income may be addressed because it may be eliminated 
from the final model due to the large amounts of missing data for this variable. Also, age may be 
a better predictor of intended outcomes which may assist with understanding how educational 
level may have an impact on the outcomes of interest in this study. 
Lastly, it is acceptable for an exploratory study to use slightly lower thresholds for the 
perception variables that were developed using factor analyses.  The exploratory factor analysis 
alone allows alike variables to be grouped together and make a more parsimonious set of 
variables.  Thus, the limitation of questionnaire items measuring constructs of the HBM in the 
baseline assessment was addressed through performing the factor analysis.  Low alpha levels for 
perceived benefits were noted in the discussion of results for this study.  The other 3 constructs 
(perceived susceptibility, severity, and barriers) appear to be adequate for measuring the intended 
components of the HBM. 
In summary, the exploratory nature of this study will offers critical information regarding 
STD testing behaviors and was not used to test the utility of the model concerning STD testing 
behaviors.  Instead, the focus was to examine the relationships between variables and 
characterize predictors of the outcome variables. 
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5. CHAPTER V. 
5.1. RESULTS 
This chapter presents the results of this exploratory study. Included in this chapter are brief 
discussions of descriptive statistics, univariate analyses, and multivariate analyses.  (Tables of 
results are displayed in Appendix A). 
5.1.1. Total Number of STD Tests Completed  
Characteristics of the General Population 
 
Table 5.1-1 provides baseline socio-demographic, psychosocial, and health-related 
characteristics of the population under study.  This study population is made up of 171 DAISY 
participants who completed the entire two year study at the beginning of this investigation.  More 
than half of the participants in this study self-identified as Black or African American (81%, n = 
138) while the remaining participants self-identified as either White (10%, n = 17) or other race 
(9%, n = 16).  Approximately, 75% of all participants were less than 20 years old (n = 129) and 
60% had less than high school education (n = 103).  The average age of participants was 18.8 
years (SD = 2.7).  Of all study participants, 47 women (28%) completed high school and 21 
women (12%) had greater than high school education.  Additionally, more than half of all study 
participants did not attend church (65%, n = 112). 
 More than half of the women in this study were recruited from clinic populations (72%, n 
= 123) and had more then 2 sexual partners within the past year (63%, n = 108).  Approximately 
41% of participants (n = 70) had symptoms of an STD while about 70% (n=120) were currently 
taking antibiotics for their most recent Chlamydia or gonorrhea infection. Out of the 120 women 
reporting antibiotic use, approximately 47% (n = 57) reported that they were having symptoms 
of an STD at the baseline clinic visit. Eighty-three respondents (36%) reported that they had 
condom problems in the past 6 months and 95 (56%) said they had a past history of an STD. 
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Most women did not participate in douching behavior (74%, n = 126) or report a history of 
sexual abuse (91%, n = 156). However, more than half of study participants did report that their 
first age of intercourse was between the ages of 12 and 14 (53%, n = 91). 
 In the area of psychosocial variables, more than half of study participants are depressed 
(57%, n = 97) and stressed (54%, n = 92).  While 54% (n = 92) believe that acquiring an STD is 
a matter of fate or luck, 45% (n = 77) believe they are in control of whether or not they get an 
STD and 40% (n = 69) believe that others play a role in whether they get an STD.  In addition, 
most participants had lower social support scores in this study (54%, n = 93). 
 For substance use, 37% (n = 63) currently smoke cigarettes, 17% (n = 22) used marijuana 
more than 9 times in the past month, and 50% (n = 86) say they drink alcohol once a month or 
less. 
 Background Variables 
 A preliminary univariate regression analysis was employed to determine which 
background factors were most associated with the outcome (See Table 5.1-2). This step was 
undertaken to reduce the amount of variables that would be used in the final analyses to 
determine the best model which explains the data.  The p-value given in this table is based upon 
the calculation of a partial F statistic in univariate regression analyses between each background 
variable separately and the outcome.  This statistic allowed for the control of the intervention 
variable (whether the participant was randomized to the home sampling group or clinic group) 
while conducting the univariate regression analysis. The intervention group variable was 
included because it was statistically significant to the outcome variable in a univariate analysis (p 
= 0.075).   Additionally, the mean number of STD tests completed is given for each background 
variable in this table.  
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 Figure 5.1 shows that the total number of STD tests completed by study participants 
range from 0 to 16 tests during this period. Many of the means for the number of STD tests 
completed range from approximately 3 to 4 tests during the two-year study period.  Higher mean 
number of STD tests ( > 4 tests) were associated with having symptoms of an STD (mean = 
5.04), age less than 20 years old (mean = 4.26), less than high school education (mean = 4.26), 
having a past history of sexual abuse (mean = 4.71), age at first intercourse being greater 
than or equal to 15 years old (mean = 4.28), having higher stress scores (mean = 4.13), having 
reported condom problems in the past 6 months (mean = 4.40), believing that others have control 
over whether one gets an STD (mean = 4.20), cigarette use (mean = 4.02), using marijuana more 
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Figure 5-1   Total Number of STD Tests During the 2-yr Study Period  
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than 3 times in the past month (means 4.42 and 4.51), drinking alcohol 2 to 4 times a month or 2 
to 3 times a week (means = 4.27 and 4.75, respectively), and current use of antibiotics (mean = 
4.53).  There was also a high mean for those who reported no current use of antibiotics in the 
study (mean = 4.80).  The overall mean number of tests for all study participants was 3.85 tests 
completed over the 2-year study period. Significant background factors (p < .10) that will used 
for the final analyses regarding the number of STD tests completed are age (p = 0.071), race (p = 
0.011), education (p = 0.048), symptoms of an STD (p = 0.0003), current antibiotic use (p < 
0.0001), and having condom problems (p < 0.0001).  Also, the randomized group assignment 
variable (home sampling intervention vs. reminder for STD testing) was controlled for in the 
final analyses. 
Health Belief Model Perceptions 
 In Table 5.1-3, the frequency and percent of health belief model perceptions for study 
participants are presented. High and low categories for the perceptions are based upon the 
measure’s median score (or mean score for perceived benefits).  These questionnaire items are 
based on Likert-type responses that range from 1 to 6 (1 = strongly disagree, 6 = strongly agree).   
One should note that the perceived benefits of STD testing variable only produced high response 
values.  Most respondents agreed on items concerning the benefits of STD testing.  Thus, this 
item was categorized for high and low based on a mean of 6 (<6 and 6+). 
 Results for HBM perceptions reveal that 58% perceived high susceptibility of STDs (n = 
100) and 74% perceived high benefits of STD testing (n = 126).  Responses by study participants 
were similar for perceived severity to STDs and perceived barriers of STD testing. Fifty-three 
percent (53%, n = 91) perceived low severity to STDs and low barriers to STD testing.  High 
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perceived severity to STDs and high perceived barriers of STD testing were 47% percent each (n 
= 80).   
 In Tables 5.1-4 and 5.1-5, results are presented on background variables and their 
association with HBM perceptions.  These tables show a simple logistic regression analysis that 
was performed between the dichotomized perception measures (high and low) and all 
background (predictor) variables used in this study. Odds ratios are presented to show direction 
of association between background and perception variables.  The only inverse relationship that 
is presented in this table is between background variables and perceived susceptibility because 
lower value responses to these items demonstrate higher perceived susceptibility to STDs (See 
Table 5.1-4). So, lower perceived susceptibility to STDs was significant for age at first 
intercourse, race, and douching behavior.  In comparison to Black race, other race has about 5 
times more odds for perceiving less susceptibility of STDs (OR = 5.15, p-value = 0.030).  For 
young women who reported their age at first intercourse as greater than age 17, they had 
approximately 6 more times the odds of perceiving less susceptibility to STDs in relation to 
those with younger ages at first intercourse (OR = 6.23, p-value = 0.051).  Also, perceiving less 
susceptibility of STDs for young women was significant for women participating in douching 
behavior (OR = 2.81, p-value = 0.029). 
Higher perceived severity to STDs (Table 5.1-4) was significantly associated with 
attending church (OR = 2.24, p = 0.074), having more social support (OR = 2.18, p = 0.074), and 
believing less that acquiring an STD is a matter of fate or bad luck (OR = 0.391, p = 0.021).   
Higher perceived benefits of STD testing (Table 5.1-5) among study participants was 
significant for increasing age (OR = 0.649, p = 0.020), having attained education beyond high 
school (OR = 40.4, p = 0.020), Black race in comparison to White race (OR = 0.150, p-value = 
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0.027), not being depressed (OR = 0.288, p-value = 0.042), having symptoms (OR = 6.37, p-
value = 0.001), not smoking cigarettes (OR = 0.267, p-value = 0.024), having an increasing 
number of sexual partners in the past year (OR = 0.833, p-value = 0.024), and having condom 
problems (OR = 2.70, p-value = 0.078).  In addition, interesting relationships reveal that young 
women who drank alcohol monthly or less in comparison to not drinking at all (OR = 2.40, p-
value = 0.032) and who had low social support in comparison to high social support (OR = 
0.300, p-value = 0.059) perceived higher benefits to STD testing. 
Lastly, having higher perceived barriers to STD testing (Table 5.1-5) was significantly 
associated with age at first intercourse (OR = 6.66, p-value = 0.013 – lower age at first 
intercourse and OR = 5.65, p-value = 0.056 – older age at first intercourse) and believing that 
acquiring an STD is determined by other people (OR = 3.77, p-value = 0.002). A variable that 
came close to being significant was using marijuana in the past month more than 9 times in 
comparison to not using marijuana at all as a barrier to STD testing (OR = 0.423, p-value = 
0.101). 
 In order to determine what HBM perceptions are associated with the total number of STD 
tests completed among study participants, a univariate linear regression analysis was employed 
between HBM perceptions and the outcome variable (See Table 5.1-6). This table shows that the 
only significant association between completing an increasing number of STD tests completed is 
having increasingly higher perceptions of severity to STDs (p = 0.097). 
Final Analysis 
 A final stepwise linear regression model to evaluate what factors best explain the total 
number of STD tests completed by study participants can be seen in Table 5.1-7.  This analysis 
includes all significant background and perception variables from Tables 5.1-2 and 5.1-6. The 
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intervention (randomized group assignment) variable has been controlled for in this analysis.  
Thus, the final model demonstrates that having symptoms (p-value = 0.059), current antibiotic 
use (p-value < 0.000), and having had condom problems (p = 0.044) as the most significant 
factors for understanding the total number of STD tests completed outcome. 
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6. CHAPTER VI. 
6.1. DISCUSSION  
This chapter examines the results of this investigation and discusses plausible 
explanations for the findings presented in chapter five.  Additionally, implications concerning the 
results will be discussed in relation to practice, theory, policy, and future research initiatives.  
The discussion will be organized by background factors, health belief model perceptions, and the 
overall analysis. 
6.1.1. Study Overview 
Overall, the findings in this study demonstrate that there are a myriad of factors which  
may impact STD testing behaviors among young women.  However, a description of the 
population researched in this exploratory study is warranted because the results may be simply 
reflective of the sample chosen for this investigation.  The majority of the study population was 
recruited from clinic settings (approximately 70%) which mean that they are young women who 
are already receiving STD services and may be somewhat motivated to seek STD testing.  The 
smaller population of young women who were recruited from the community may be less 
motivated to seek STD care or are not as knowledgeable about where to seek STD testing and/or 
care.  So, most of the population in this study represents a unique segment of the population who 
are seeking care, but whether they delayed in seeking STD care or other specifics about the STD 
testing behaviors cannot be determined from this investigation.   
 This study population also demonstrates that women who are attending STD clinics may 
be individuals who are at also high risk for STDs as well as other risky outcomes. Many of these 
women were younger than age 20, had past histories of STD acquisition, were currently taking 
antibiotics for their most recent Chlamydia or gonorrhea infection, and reported that their first 
age of intercourse was between the ages of 12 and 14.  Most of these factors reveal that there are 
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multiple risk factors for STD acquisition and that individual characteristics or behaviors are just 
one aspect of the problem which needs to be addressed in order to control the STD epidemic. 
Hence, strategies to prevent STDs by researching what significantly impacts STD testing 
behaviors can offer good insight in addressing prevention efforts among young women. 
Therefore, studies such as the research undertaken in this paper significantly add to the 
literature concerning what factors facilitate or hinder STD testing.  In addition, this study 
investigates whether HBM constructs can be assist in explaining STD testing behaviors.  Young 
women’s’ perceptions of STD testing and participation in STD-preventive behaviors (i.e. 
condom use, decreasing number of partners, and getting an STD test every 6 months, etc.) is of 
utmost importance when attempting to reduce and eliminate the burden of STDs in the US.  
These factors should be addressed as part of STD prevention programs that are developed by 
public health or healthcare institutions. 
There are also many public health implications for examining predictors of STD testing 
behaviors because this information can assist with increasing and improving access to quality 
STD services and potentially improve overall STD screening and testing procedures within 
numerous health care institutions.  Thus, the current research study demonstrates the complexity 
of STD testing behaviors, and also highlights some background and perception variables that 
may be necessary to address when developing STD prevention programs for young women at 
high risk for STDs. Additionally, this information may be helpful in understanding behaviors 
involved in the Human Immunodeficiency Virus (HIV) epidemic which is also an increasing 
public health issue among young women. 
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6.1.2. Background Variables 
In general, the study findings revealed that there are numerous background factors that may 
impact STD testing behaviors.  For this study, background factors included a wide range of 
variables: socio-demographic, psychosocial, and health-related factors. Studies have shown that 
individual characteristics play a major role in health care seeking behaviors (Amaro & 
Gornemann, 1991).  Factors such as age (Fiscus et al., 2004); socioeconomic status (Crosby et 
al., 1999; Fortenberry, 1997); educational level (Chacko et al., 2004) have been found to 
determine where individuals seek treatment, what barriers there are to STD treatment, and 
reasons for delaying treatment.    
In preliminary analyses, the present study found that age, race, education, having 
symptoms of an STD, current antibiotic use, and having condom problems in the past 6 months 
were significant factors related to the total number of STD tests completed by participants.  
These analyses were controlled for the intervention variable which was used to detect any 
differences between young women who were randomized to the home sampling group versus the 
STD testing reminder group.  In addition, all of the significant factors are also variables where 
the mean number of STD tests completed for that specific variable was higher than the overall 
study population mean for STD tests completed -- 3.85 tests. Thus, background factors that were 
significant to the outcome were associated with an increase in the number of STD tests 
completed during the two-year study. 
A closer look at the intervention variable revealed that women randomized to the home 
sampling group had a mean number of tests of 4.29 during the study period while the reminder 
testing group had a mean of 3.42 STD tests during this time period.  Since the efficacy of the 
intervention is not being evaluated in this study, we can not determine if the mean number of 
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tests were higher for the home testing group due to the intervention.  However, it should be noted 
that there were more tests completed by the home sampling group for the participants in this 
sample of the DAISY study. 
 Age in this study may be difficult to characterize because more than half of study 
participants were younger than age 20.  Yet, age was still a significant factor to the outcome 
which means that there are young women who are getting STD tests and this also means that 
they are potentially young women who are also being diagnosed with an STD. Research suggests 
that younger individuals may delay seeking care because they do not perceive themselves at risk 
of infection (Amaro & Gornemann, 1991), however, they are also more likely to seek STD care 
at family planning or STD clinics (Brackbill et al., 1999).  More than 70% of the women in this 
study were recruited from STD clinics which may explain why younger individuals may believe 
that these venues are accessible for STD testing and care.  On the other hand, we cannot 
conclude that these young women actually delayed in seeking care which may be a true for this 
population also. 
Another background factor that was significant to the outcome was race. Race may have 
played a factor in the outcome for two reasons.  One reason was due to the fact that more than 
80% of study participants were of African-American race.  So, their STD testing behaviors could 
be more significant than the smaller numbers of White and Other populations in this study.  Even 
though White and Other populations seem to have larger means for the total number of STD tests 
completed, this may not demonstrate true differences among the races.  Second, race in this study 
may not indicate accurate behaviors because many of the White and Other populations were 
recruited from the community and the community had to have specific criteria (i.e. greater than 2 
sexual partners in the past year) which may be the cause of the differences in number of STD 
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tests completed.  White and Other race individuals in the study had to have reported riskier 
behaviors than the general population in order to be eligible for the study, and so this population 
may seek more STD testing than usual.  In conclusion, race may be significant to the number of 
STD tests completed, but the ability to detect differences among the races is hindered due to the 
small number of White and Other races in this investigation. 
Other background factors that were significant to the outcome and may provide insight 
regarding STD testing behaviors are having symptoms at baseline, current antibiotic use, and 
having had condom problems in the past six months.  Overall, more than 50% of the women in 
this study reported that they did not have symptoms at baseline. Yet, the women in this study 
who did report having symptoms had a higher mean number of STD tests completed than women 
who did not report symptoms. This shows that women may actively seek STD care if they 
experience symptoms of an infection, but this should not always be the case for STDs because 
infections such as Chlamydia and gonorrhea are mostly asymptomatic. Evidence reveals that 
women who indicate that they have symptoms of STDs usually delay seeking care until the 
symptoms get worse (Aral & Wasserheit, 1998), or even attempt to self-treat themselves before 
seeking care (Aral & Wasserheit, 1998; Fortenberry, 1997).  Once again, we were not able to 
ascertain the duration of time that it took women to seek care, but this data does show that 
women may seek STD testing more aggressively because they are experiencing symptoms of an 
STD. 
 Much of the literature shows that part of the delay in acquiring STD testing or care has 
been due to self-treatment of STDs.  Individuals who may have had an STD before or who 
already have antibiotics or other nonprescription medications in their possession may use these 
drugs to treat their symptoms before they seek medical attention. This is dangerous because 
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complications due to the infection can worsen if not treated properly and possibly give the young 
woman a false sense of perceiving that she is cured from the disease. Other thoughts that should 
be noted concerning women who are currently taking antibiotics and seeking STD testing, may 
be that seeking additional tests is linked to non-compliance with treatment regimens for previous 
STD diagnoses.  In addition, young women may be re-infected with Chlamydia or gonorrhea 
which prompts their return for STD testing.   High STD re-infection rates have been suggested in 
the literature to be important in changing current STD screening recommendations (Burstein et 
al., 1998), but this also shows that young women are not modifying their high-risk sexual 
behaviors to account for current STD infections.    
The issue of having condom problems as a catalyst for seeking STD testing is an 
interesting finding in this study. This basically demonstrates that those women who reported 
condom problems in the past six months were more likely to seek STD testing.  Although this 
appears to be a positive result for seeking STD care, it also reveals that improper condom use is 
still a factor among individuals.  This is another important issue to address when developing 
STD prevention programs because the literature does show that there are high rates of 
inconsistent condom use and that proper use of condoms is also a risk for acquiring an STD. 
Variables which were associated with a higher mean number of STD tests completed, but 
were not significant to the outcome are past history of an STD, age of first intercourse greater or 
equal to age 15, past history of sexual abuse, believing that others play a role in whether the 
participant gets an STD, stress, cigarette smoking, marijuana use, and alcohol use.  These 
variables may be important issues to address when seeking to understand what factors impact 
healthcare seeking behaviors or perceptions of STD testing or care. Women who appear to 
engage in riskier behaviors may access services more often which increase their chances for 
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obtaining an STD test, but it also interesting that having a past history of an STD, stress, and 
sexual abuse also led to a slight increase in the number of STD tests completed.  Young women 
with past STD history should already know what to do to prevent further infections, but this 
study supports previous literature showing that women rarely change behaviors to prevent STDs 
after being diagnosed with an STD (Fortenberry, 1997; T. Kershaw et al., 2004). Additionally, 
background factors such as stress and sexual abuse would appear to be a barrier to seeking STD 
testing for women.  However, being stressed or having a history of sexual abuse for this 
population was not a barrier, but a possible force which prompted women to seek STD testing.  
Yet, caution must be used in interpreting these data because there were only a few number of 
participants who reported being sexually abused (n = 14, 8%). 
Background factors which have been found in previous literature to influence STD seeking 
behavior, but were not significant to the total number of STD tests completed alone in this study 
are depression and social support. Depression has been shown to be a barrier to seeking care 
among diverse populations (Amaro & Gornemann, 1991) while social support from friends and 
sex partners concerning STDs positively influenced seeking STD healthcare (Fortenberry & 
Zimet, 1999).  However, these conclusions were not apparent in this study. 
 In conclusion, there are many background factors which show higher number of STD 
tests completed in this study, but only age, race, education, having symptoms of an STD, having 
had condom problems in the past six months, and current antibiotic use were significant to the 
total number of STD tests completed by study participants.  Some of the background factors such 
as age, race, and education are mostly likely significant due to the nature of the population under 
study.  Many participants were of African-American race and young so this does not demonstrate 
true differences among groups.  However, this does reveal that there are many young African-
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American women in Pittsburgh, PA who are accessing STD services and being infected by 
Chlamydia and gonorrhea at alarming rates.  Other significant factors such as current antibiotic 
use and having had condom problems in the past 6 months show that there are many issues that 
need to be addressed in improving the self-efficacy of adherence to treatment regimens and 
condom use. Additionally, having symptoms serves as a catalyst for acquiring an STD test in this 
study is not necessarily a positive result because most Chlamydia and gonorrhea infections are 
asymptomatic.  These results reveal that there are many challenges in understanding testing 
behaviors of young women, but it is obvious that specific individual characteristics (being 
young, past history of an STD, etc.) and STD prevention program characteristics (i.e. education 
concerning proper medication use, proper condom application, and adherence to prophylactic 
regimens, etc.) need to be addressed to positively influence STD testing among similar 
populations.  In addition, background factors such as church attendance, number of sexual 
partners, depression, stress, sexual abuse, alcohol and marijuana use, and douching behavior 
should be further researched to understand their impact on willingness to seek STD care. 
6.1.3. Health Belief Model Perceptions 
Overall, the majority of participants in this study perceived high susceptibility to STDs, low 
severity to STDs, high benefits of STD testing, and low barriers to STD testing.  This study is 
unique because it uses all components of the HBM to characterize a STD testing behavior. 
Currently, there is very limited literature regarding how the components of the Health Belief 
Model influence STD testing behaviors and whether the HBM is suitable for explaining STD 
testing behaviors. 
Association with Background Factors 
 In this study population, having a lower perceived susceptibility to STDs was 
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significantly associated with younger age at first intercourse, other race, and participating in 
douching behavior.  So, young women in this study who were older at first intercourse, were of 
African-American race, and participated in douching behavior had higher perceived 
susceptibility to STDs.  Previously, perceived susceptibility was found to be a stronger predictor 
of preventive health behavior (Janz & Becker, 1984; Rosenstock et al., 1994). Evidence also 
reveals that many younger individuals misperceive their risk of STDs (Ford, Jaccard, Millstein, 
Viadro et al., 2004), however, perceived risk of infection has been associated with being Black, 
having a diagnosis of an STD, and reporting current symptoms (Ford, Jaccard, Millstein, 
Bardsley et al., 2004).  Therefore, young women who appear to be older when they first have sex 
or are douching in possible attempts to self-treat symptoms of an STD are more likely to have 
higher perceptions of susceptibility to STDs.  It may also be true that having higher perceptions 
of susceptibility to STDs can be influenced by experiences of already having had an STD and 
becoming more knowledgeable about the symptoms associated with Chlamydia and gonorrhea 
infections. 
 Higher perceptions of severity to STDs were significantly associated with church 
attendance, higher levels of social support, and believing less that STDs are due to chance.  
These individual factors may be positive influences which give knowledge to young women 
regarding the consequences of sexual behaviors such as getting an STD or becoming pregnant. 
This is because the severity question deals with the inability of women to get pregnant if they get 
a Chlamydia or gonorrhea infection.  In addition, young women who believe that STDs are not 
due to chance or bad luck may understand the severity of these infections better more efficiently 
than women who believe that STDs are a matter of luck.  Overall, perceived severity to STDs 
has not been sufficiently studied regarding STD testing or acquisition.  In one study, a 
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combination of perceived susceptibility and severity were examined to understand adolescents’ 
worry about becoming infected with an STD.  Most adolescents in this study were not worried 
about STDs, but those who had higher perceptions of susceptibility and severity had histories of 
an STD, low partner communication and unable to negotiate condom use (Crosby, DiClemente, 
Wingood, Sionean, Harrington, Davies et al., 2001). Another study found that perceiving 
severity of STDs did not significantly impact condom use (Zak-Place & Stern, 2004). Thus, 
correctly perceiving the severity of STDs can be representative of positive influences in an 
individual’s life and the control they believe they have in their behaviors which can ultimately 
affect their STD-preventive behaviors.  It should also be noted that there were larger number of 
young women in this study who may not relate to the inability to get pregnant because they may 
not even view pregnancy at their age as a viable outcome. 
 Young women in this study who had higher perception of benefits of STD testing were 
significantly associated with increasing age, having obtained higher education, race, not being 
depressed, having symptoms of an STD, having condom problems, and an increasing number of 
sexual partners.  Higher perceptions were even associated with non-cigarette and cigarette use, 
having low social support, and drinking alcohol less.  One reason why perceptions of benefits 
include many background factors is because the majority of women in this study reported that 
they perceived many benefits to STD testing.  In addition, this variable had a lower reliability 
coefficient than the other perception items so this may be a problem variable and not effectively 
measure perceived benefits of STD testing.  Overall, literature has shown that perceived benefits 
is a better predictor of sick-role behavior than preventive health behaviors (Janz & Becker, 1984; 
Rosenstock et al., 1994).  In addition, perceiving more benefits of HIV testing was associated 
with individuals who were more likely to seek testing (Dorr et al., 1999).  As a result, the only 
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conclusion that one can draw from these results is that many women do perceive that there are 
benefits to STD testing, but determining whether they sought STD testing for these perceptions 
cannot be determined in this study. 
 The last perception variable assessed in this study for the HBM was perceived barriers to 
STD testing.  This construct was significantly associated with age at first intercourse and the 
belief that others play a role in whether one gets an STD.  The use of marijuana more than 9 
times in the past month was also close to being a significant factor to perceiving barriers to STD 
testing (p = 0.101).  It is evident that barriers to STD testing affect women who had a first sexual 
experience at younger and older ages.  This study also revealed that young women who believe 
they have less control over whether they get an STD because others play a role in whether they 
get an STD may give insight to women who feel powerless in the decision to protect themselves 
against STDs.  
Much of the literature regarding barriers to STD testing have focused on issues including: 
fear of gynecological exams (Burack & Meyer, 1997); stigma (Fortenberry et al., 2002; 
Lichenstein, 2003); and, STD testing issues such as confidentiality (Amaro & Gornemann, 1991) 
and provider and clinic characteristics (Barth et al., 2002; Dienes et al., 2004; Tilson et al., 
2004).  So, perceiving barriers to STD testing is not an unusual phenomenon, especially for 
young and older ages alike.  Women do not like being stigmatized for seeking an STD test, they 
fear pelvic exams, they may be apprehensive to seek care if participating in illegal activities, they 
may feel their confidentiality is not maintained, or they may feel that their powerlessness in 
relationships keeps them from seeking an STD test.  Therefore, STD testing programs need to 
address issues related to barriers to care such as improving provider training regarding STD care, 
making STD testing and clinic environments more confidential, and finding less invasive 
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techniques to perform an STD test.  Also, programs should encourage those using marijuana or 
participating in other risky behaviors to seek STD testing for improving their overall health. 
Association with Outcome Variable 
The HBM perception variables were placed in a univariate analyses with the total number 
of STD tests completed outcome.  Each variable was fitted separately in a model that controlled 
for the intervention variable and assessed its association with the outcome of interest.  The only 
perception variable that was significant to an increasing number of STD tests completed was 
perceived severity (p = 0.097).  This means that higher perceptions of severity to STDs among 
young women were related to completing an increasing number of STD tests during the study 
period.  This conclusion is surprising because out of all the HBM constructs, perceived severity 
has been found to be the least powerful predictor of preventive health behavior among previously 
published studies (Janz & Becker, 1984; Rosenstock et al., 1994). In addition, Zak-Place and 
Stern (2004) reported that severity of STDs was not significant to intended STD testing among 
college students (82% White, 6% Black).  Hence, perceived severity may not traditionally be 
associated with preventive health behavior, but this study revealed that knowing consequences of 
STDs can influence young women to seek STD testing at slightly significant higher rates. 
6.1.4. Final Model for Understanding the Total Number of STD Tests 
The final model in this study included all significant background factors (age, 
education, race, having symptoms, current antibiotic use, and having condom problems) and 
significant perception variable, perceived severity.  In this final model, a multivariate stepwise 
linear regression model was employed which resulted in three statistically significant factors (p <  
0.10). These factors were having symptoms of an STD at baseline, having had condom problems 
in the past six months, and current antibiotic use.  The perceived severity variable did not remain 
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significant with all the background variables in the model.  Likewise, age, education, and race 
were removed from the model because of the addition of perceived severity.  This may 
demonstrate that perceptions of severity were more likely to be related to age, education, and 
race in this study. Additionally, these results show that HBM constructs or the questions used to 
measure these components were not sufficient enough to characterize STD testing behaviors 
among young women in this population. 
6.2. CONCLUSION 
The modified schematic design of the HBM was used in this study to guide the research 
which explored STD testing behaviors among young women at risk for STDs in Pittsburgh, PA.  
The model shows that background variables alone, perception variables alone, and/or 
background and perception variables together can potentially influence the behavior of interest, 
number of STD tests completed during a two-year study.  The results of this investigation found 
that none of the Health Belief Models perceptions, except perceived severity, were associated 
with obtaining an STD testing during the study period.  Further analyses demonstrated that when 
perceived severity was added to other significant background factors, it was no longer significant 
to the outcome.  Thus, the only significant factors to the number of STD tests completed 
outcome was having symptoms at baseline, having had condom problems in the past six months, 
and current antibiotic use. 
Theoretical Conclusions 
 The results of this exploratory study does not suggest that the Health Belief Model is not 
useful for understanding STD testing behaviors, but that the specific questions utilized may not 
be sufficient for assessing this type of outcome.  The analyses provided that assessed the 
relationship between background factors and perceptions appear to give more conclusive results 
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concerning how young women perceived STDs and STD testing.  Thus, the Health Belief Model 
does show that perceptions can be influenced by various background factors and may be 
essential in developing programs that aim to modify perceptions of STDs and STD testing in 
diverse individuals. 
  It is also not clear whether STD testing should be labeled a preventive health behavior or 
a sick-role behavior in this study. Since much of the previous empirical evidence that supports 
the HBM discusses its influence in this manner, there needs to be more information to determine 
if STD testing should be identified as a preventive health technique and not as sick role behavior.  
However, results from this study reveal that most young women used recognition of symptoms 
and/or current antibiotic use as a potential catalyst for obtaining an STD test while a preventive 
health behavior may be suggested as the motivating factor for participants who mentioned they 
had condoms problems in the past six months.  An exploration of all HBM components, instead 
of specific perceptions which have been used in most reviewed articles, should be utilized in 
future research to understand STD testing behavior. 
 In conclusion, the results of this study demonstrate that the manner in which the HBM 
was used in this study was not adequate in explaining the number of STD tests completed.   
However, the HBM could be useful for assessing STD testing behaviors if more research was 
performed to determine adequate questions that could be used to measure HBM components 
associated with STD testing and if STD testing is researched as a preventive health behavior 
versus a sick-role behavior.  Moreover, the HBM provided interesting results regarding how 
background factors impact perception variables in this study.  Hence, theoretical considerations 
for understanding STD testing behaviors would be to enhance the development of questions for 
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perception variables that adequately measure diverse aspects of how a myriad of factors affect 
perceptions and then ultimately behaviors. 
 
Practical Implications 
 The background factors that were found in the final model to be significant to an 
increasing number of STD tests completed provide helpful suggestions for STD testing services 
and/or STD prevention programs.  These practical suggestions would address symptom 
recognition, having condom problems, and using antibiotics effectively as part of program 
components.  In addition, programs should encourage perceptions among individuals that prompt 
routine STD testing for those who are sexually active is important. Furthermore, it should be 
noted that this study identified several, diverse background factors concerning study participants 
which can be further explored as risk factors for STD testing behaviors.  Background factors 
such as age, race, education, church attendance, having had condom problems in the past 6 
months, age at first intercourse, health locus of control, and marijuana use may be important for 
understanding STD testing behaviors. Issues related to income or SES influences were not used 
in this study due to lack of data, but many women reported that they had some type of insurance 
(i.e. government health insurance, etc.) and did not have problems accessing care (i.e. no large 
wait times, very little out of pocket expenses for care or medications, etc.). 
 In addition, it was mentioned earlier that many of the women who reported symptoms at 
baseline were not necessarily women who were currently using antibiotics which means that 
recognizing symptoms and possible re-infection of STDs or self-treatment are critical issues to 
address for STD prevention purposes.  These issues may be difficult to address because many 
STDs are asymptomatic in women, but educating younger individuals about consequences of 
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STDs, risks associated with Chlamydia and gonorrhea and proper methods to care for their 
health (i.e. obtain STD testing every 3 to 6 months if sexually active) will be essential to 
controlling the STD epidemic. 
On the other hand, there needs to be modifications in the way healthcare professionals are 
trained to assess young women and men regarding sexual health issues. Evidence shows that 
provider characteristics are critical in understanding the consequences of STDs and engaging in 
behaviors that prevent complications due to STDs (i.e. condom use, adherence to medication 
regimens, routine STD testing, etc.). This is a major reason why STD testing behaviors were 
used in this exploratory research instead of STD screening behaviors.  The use of STD testing 
behaviors implied that young women had to be motivated in some way to seek STD testing while 
STD screening behaviors can be a combination of a recommendation from a provider and patient 
decision-making.  Thus, STD testing was chosen because the goals of this study were to 
understand how individuals perceive STDs and STD testing and if this affects how young 
women seek STD tests. 
Additionally, some of the barriers to STD testing could be addressed in newer STD 
prevention programs that aim to increase STD testing among individuals at high risk for STDs.  
Some options are to: 1) develop less invasive techniques such as vaginal swab sampling or urine 
tests; 2) discover what settings are most effective for specific populations to access services; 3) 
train providers to be more comfortable and able to encourage STD testing (i.e. improve clinic 
environments, gynecological rotations, etc.; and 4) find other aspects of everyday life that 
provide a foundation for making healthier sexual decisions (i.e. church attendance, positive 
social support, etc.). 
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In conclusion, practical implications for STD testing services and STD prevention 
programs can address background and perception issues that were discussed in this study.  
Factors related to health were more likely to explain STD testing behaviors.  Other background 
factors and perceptions were not significant to the outcome.  However, results on what 
influenced perception variables and other background factors demonstrate that STD prevention 
programs and providers need to focus educational information given to these women on the 
asymptomatic nature of STDs, consequences of untreated STDs, correct condom usage, and 
proper adherence to treatment regimens. 
Policy Recommendations 
 Based upon the final results of this study, it is obvious that there needs to be screening 
and policy recommendations which encourage young women and providers to actively engage in 
STD testing behaviors.  It appears that sexually active individuals may need to seek STD testing 
more frequently than 6 months due to the high rates of re-infection in certain populations.  This 
study also reveals that women who are seeking testing have symptoms at baseline or are already 
taking antibiotics for a recent infection.  This means that more aggressive prevention techniques 
such as discussing prevention techniques at the clinic visit (i.e. proper use of condoms, 
medication adherence, complications of untreated STDs, etc.) should be part of STD testing or 
screening protocol.  In addition to this being a policy recommendation, there should be health 
quality measures which monitor certain details surrounding STD testing experiences. 
Policies should also encourage providers to assess all females and males who are sexually 
active for their sexual health practices (no matter what the age).  This could be an opportunity for 
providers to initiate open discussion with individuals regarding their behaviors and what services 
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are available that can better address some specific issues they make have regarding this 
phenomenon. 
In addition, STD prevention messages in the mass media must be of utmost importance in 
the US.  Instead of just HIV, there needs to be mass awareness of what could be the 
consequences of unprotected sexual behaviors or how risky sexual practices could make persons 
at high risk for specific STDs.  These messages do not have to discuss sex directly, but highlight 
ranges of ages and races in discussing how STDs are a public health problem for our nation. 
Future Research Initiatives 
 In  summary, although the results of this exploratory study provide a broad array of 
concepts that may be associated with STD testing behaviors among high-risk young women, 
there are only a few background factors that were found to significant to the outcome of interest. 
Further research on how behavioral, socio-demographic, clinical, and cognitive factors impact 
STD testing behaviors are essential to controlling the STD epidemic.  Issues that have been 
discussed surrounding theoretical, practical, and political conclusions for this paper aim to give 
attention to an area of STD literature that has been given little focus.  It is centrally important to 
understand utilization of STD services so that they can be improved and ultimately reduce and 
eliminate the STD epidemic in the US.  Therefore, studies such as the one provided can 
demonstrate the research needs for young women concerning STDs and assist with determining 
innovative methods to encourage STD testing among individuals at high-risk for Chlamydia and 
gonorrhea.
 125
 
 
 
APPENDIX A 
 
Result Tables 
 
 
 
 
 
 
 
 
 
 
 126
Table 5.1- 1 Baseline Socio-demographic, Psychosocial, and Health-Related Characteristics 
         of Study Participants (Frequency and Percentage) 
 
 
 
 
Total Number of STD Tests 
Completed  
N = 171 
Variable                   n                % 
Age 
                                                 < 20 
                                                 > 20 
 
 
                129              75 
                  42              25 
Race 
                                               Black 
                                               White 
                                               Other 
 
 
                138              81 
                  17              10 
                  16                9 
Education 
                                  < High School 
                            High School Grad 
                                  > High School 
 
 
                103              60 
                  47              28 
                  21              12 
Attend Church 
                                                  Yes 
                                                   No 
 
 
                  59              35 
                112              65 
# Partners in Past Year 
                                                 < 2 
                                                 > 2 
 
 
                  63              37 
                108              63 
Recruitment Group 
                                               Clinic 
                                      Community 
 
 
                123              72 
                  48              28 
Randomized  Group Assignment 
                                
                              Home sampling 
                                  Clinic testing 
 
 
 
85 50 
86 50 
Symptoms of STD* 
(n = 169)                                   Yes 
                                                   No 
 
 
                  70              41 
                  99              58 
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Table 5.1 – 1     Continued – Baseline Characteristics 
 
 
Currently Taking Antibiotics* 
(n = 130)                                             
                                                  Yes 
                                                   No 
 
                           
                120              70 
                  10                6 
Had Condom Problems* 
(n = 145)                                 
                                                  Yes 
                                                   No 
 
 
 
                  83              36 
                  62              29 
Past History of an STD 
 
                                                  Yes 
                                                   No 
 
 
 
                  95               56 
                  76               44 
Douches                                           
                                                 Yes        
                                                   No 
 
 
                  44                26 
                126                74 
Age at First Intercourse 
 
                                               12-14       
                                                  15+ 
 
 
 
                   91               53 
                   80               47 
Past History of Sexual Abuse* 
(n = 170) 
                                                  Yes 
                                                   No 
 
 
                   14                 8 
                 156               91 
Stress 
                                                  Yes 
                                                   No 
 
  
                   92               54 
                   79               46 
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Table 5.1 -1  Continued – Baseline Characteristics 
 
 
Depression 
                                 Below Median 
                                 Above Median 
 
 
                   74               43 
                   97               57   
Health Locus of Control 
 
               Internal 
                                                                     
                                 Below Median 
                                 Above Median 
                
 
                Chance
                                                                    
                                 Below Median 
                                 Above Median 
 
 
  Powerful Others 
                                                                     
                                 Below Median 
                                 Above Median 
            
 
 
 
 
94             55 
                    77              45 
 
 
 
 
77 46 
92            54 
 
 
 
 
   102             60 
                     69             40 
Social Support 
                                             
                                 Below Median 
                                 Above Median 
 
 
 
92            54 
                     78             46 
Cigarette Use 
                                                  Yes 
                                                   No 
 
63            37 
                   108             63 
Marijuana Use in Past Month** 
(n = 128) 
                                                None 
                                       1 – 2 times 
                                       3 – 8 times 
                                          > 9 times 
 
 
                     61             48 
                     26             20 
                     19             15 
                     22             17 
 
 
 
*  Numbers do not add up to total population because there was some missing data 
** Numbers do not add up to the total population because this was the only number of 
respondents who reported participating in this behavior  
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Table 5.1- 2  Mean Number of STD Tests Completed and their Association with Baseline 
                        Socio-demographic, Psychosocial, and Health-Related Characteristics of 
                        Study Participants 
 
 
 
Variable
 
Mean Number of 
STD Tests 
Completed 
 
Mean (SD) 
 
P-value 
 
Age 
                                            < 20 
                                            > 20 
 
 
4.26 (3.3) 
2.62 (2.4) 
 
0.071 
Race        
                                         Black 
                                         White 
                                          Other 
 
 
3.61 (3.1) 
4.00 (3.2) 
5.75 (4.1) 
 
0.011 
Education 
                            
                           < High School 
                     High School Grad 
                           > High School 
 
 
                  
4.26 (3.3) 
3.40 (2.8) 
2.85 (3.4) 
 
 
0.048 
Randomized Group Assignment  
                                
                             Home sampling 
                                 Clinic testing 
 
 
 
4.29 (3.3) 
3.42 (3.0) 
 
 
 
0.075 
Attend Church 
                                           Yes  
                                            No        
 
3.95 (3.0) 
3.80 (3.3) 
 
0.862 
# Partners in Past Year 
                                                  
                                            < 2 
                                            > 2 
 
 
 
3.87 (3.0) 
3.84 (3.4) 
 
 
0.531 
Symptoms of STD* 
                                            
                                           Yes 
                                            No 
 
 
 
5.04 (3.9) 
3.03 (2.4) 
 
 
0.0003 
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Table 5.1 -2 Continued – Mean Number of STD Tests Completed 
 
Currently Taking Antibiotics* 
                                                   
                                            Yes 
                                             No 
 
 
 
4.53 (3.4) 
4.80 (2.2) 
                   
 
 
<0.0001 
 
Had Condom Problems* 
                                                  
                                            Yes 
                                             No 
 
  
              
4.40 (3.4) 
3.37 (2.9) 
 
 
<0.0001 
Past History of an STD 
 
                                            Yes 
                                             No 
 
 
 
4.05 (3.3) 
3.69 (3.2) 
 
 
0.423 
Douches                                           
                                                         
                                           Yes        
                                            No 
 
 
 
3.93 (3.2) 
3.84 (3.2) 
 
 
0.836 
Age at First Intercourse 
 
                                        12-14        
                                           15+ 
 
 
 
3.41 (2.8) 
4.28 (3.8) 
 
 
 
0.240 
Past History of Sexual Abuse* 
 
                                           Yes 
                                            No 
 
 
 
4.71 (2.8) 
3.79 (3.8) 
 
 
 
0.362 
Stress 
                                  
                          Below Median 
                          Above Median 
 
 
           
3.62 (3.4) 
4.13 (3.0) 
 
 
0.522 
Depression 
                                  
                                            Yes 
                                             No 
 
 
 
3.76 (3.1) 
3.97 (3.3) 
 
 
 
0.528 
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Table 5.1 – 2   Continued – Mean Number of STD Tests Completed 
 
 
Health Locus of Control 
               Internal 
                                                         
                          Below Median 
                          Above Median 
                                                 
              Chance 
                                                         
                         Below Median 
                         Above Median 
 
Powerful Others 
                                                         
                         Below Median 
                         Above Median 
 
 
 
3.78 (3.1) 
3.95 (3.3) 
 
 
 
3.73 (3.3) 
3.96 (3.1) 
 
 
 
 
0.751 
 
 
 
 
0.721 
Social Support           
                         Below Median 
                         Above Median 
 
Cigarette Use     
                                          Yes 
                                           No 
 
Marijuana Use in Past Month 
(n = 128) 
                        Has never used 
                                        None         
                               1 – 2 times 
                               3 – 8 times 
                                  > 9 times 
 
 
  
  
  
  
  
Drinks Alcohol 
                                           
                                    Not at all 
                          Monthly or less 
                    2 to 4 times/ month 
                      2 to 3 times/ week 
                          4 + times/ week 
 
  
  
  
  
  
 
   0.219 
Note.  Significant p-values from univa
background variable and outco
 
All models presented were con
* Numbers to do not add up to total po
       3.62 (3.1)
     4.20 (3.3)3.92 (3.4) 
3.77 (2.9) 
 
          0.907 
4.02 (3.8) 
3.76 (2.8) 
 
          0.604 
         3.88 (2.8) 
         3.39 (2.6) 
         3.22 (2.3) 
         4.42 (4.2) 
         4.51 (4.8) 
 
 
          0.191 
 
         3.88 (3.2) 
         3.60 (2.7) 
         4.27 (3.9) 
         4.75 (4.9) 
         3.50 (2.1) 
 
 
          0.668 
riate regression analyses between the specified 
me are in bold. 
trolled for the intervention group variable. 
pulation because there was some missing data 
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Table 5.1- 3  Health Belief Model Perceptions (HBM) 
                        (Frequency, Percentage, and Median Scores) 
 
 
Health Belief Model 
Perceptions 
        
         n           %       
 
Median Score (Range) 
Perceived Susceptibility of STDs 
 
                                                     Low      
                                                     High 
 
            
        71           42 
       100          58 
            
 
 
3.00 (1.0 – 6.0) 
 
Perceived Severity to STDs 
 
                                                    Low 
                                                   High 
 
 
       91           53        
       80            47 
 
 
 
4.00 (1.0 – 6.0) 
Perceived Benefits of STD Testing* 
 
                                                   Low 
                                                  High 
 
 
       45            26 
     126            74 
 
 
 
5.82 (3.5 – 6) 
(Mean = 6) 
Perceived Barriers of STD Testing 
 
                                                    Low 
                                                   High 
 
 
       91            53 
       80            47 
 
 
 
3.09 (1.45 – 5.27) 
 
 
*Low/High category based on Mean score due to higher values for scores; all other categories 
based on median score  
Based on number of participants who completed the study at this point (N=171) 
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Table 5.1- 4  Background Variables and HBM Perceptions (Susceptibility & Severity) 
                        (Univariate Logistic Regression) 
 
 
 Perceived 
ility to STDs Susceptib
Perceived  
Severity to  
STDs 
Variable     OR             p-value            (CI)               OR             p-value             (CI)           
Age 
                               (continuous) 
 
  1.05               0.728        (0.796, 1.38)   
 
    1.02               0.863        (0.793, 1.32) 
Education 
      
      
                         >HS (3) 0.533             0.538         (0.72, 3.95)   0.436             0.392         (0.065, 2.91) 
                                     <HS  (1) 
                               HS Grad (2) 
                   
 
 (Baseline category) 
  0.679             0.590        (0.166, 2.77) 
  
 
 
    0.727             0.630         (0.199, 2.66) 
  
Attend Church 
 
                                           No (0) 
                                          Yes (1) 
 
  
    1.71             0.248        (0.688, 4.24)   
 
 
 
    2.24               0.074**     (0.925, 5.44) 
Age at First  Intercourse 
 
                                          <=12 (1) 
) 
) 
Baseline category) 
  6.23             0.051*      (0.988, 39.3) 
 
    1.55                0.601        (0.297, 8.14) 
                                         13-14 (2
                                         15-16 (3
                                          >=17 (4) 
 
 
 (
    2.21             0.272        (0.536, 9.14) 
    1.10             0.895        (0.236, 4.8) 
  
 
 
  
    0.841              0.794        (0.229, 3.08) 
    0.846              0.808        (0.220, 3.26) 
Race 
                                         Black (1) 
                                       White (2) 
(Baseline category) 
  1.13             0.859        (0.281, 4.58)  
       (1.17, 22.7)    
  0.762              0.696        (0.194, 2.98) 
1.46                0.580        (0.382, 5.58) 
  
                                         Other (3) 
 
 
  
    5.16             0.030*
 
 
  
    
Stress 
                           Below Median (1) 
                           Above Median (2) 
 
 
    1.26             0.628        (0.504, 3.11) 
 
    
    0.528              0.147        (0.223, 1.25) 
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Table 5.1 -4 Continued - Background c
Social Support
Variables and HBM Perceptions (Sus eptibility & Severity) 
 
 
 
 
                           Below Median (1) 
                           Above Median (2) 
 
 
    (Baseline category) 
    1.96               0.160      (0.767, 4.98) 
 
 
 
    2.18               0.074**    (0.927, 5.15)   
Health Locus of Control – Internal 
    (Baseline category) 
    1.67               0.227      (0.727, 3.83) 
 
    0.795             0.553         (0.372, 1.70) 
 
                            Below Median (1)
                           Above Median (2) 
 
 
 
   
 
 
    
Health Locus of Control – Chance 
                          Above Median (2) 
 
 
    0.588             0.214      (0.255, 1.36) 
 
 
    0.391             0.021*     (0.176, 0.870) 
 
                            Below Median (1)     (Baseline category)    
  
 
Health Locus of Control –  
           Powerful Others   
   
    1.34               0.466       (0.612, 2.92) 
                            Below Median (1) 
                            Above Median (2) 
 
 
    (Baseline category) 
    0.875             0.758      (0.374, 2.05) 
 
 
 
  
Past STD  
                                              No (0) 
                                             Yes (1)          
   1.31               0.554      (0.531, 3.25)    1.48               0.363       (0.633, 3.48) 
 
 
 
 
 
Having symptoms 
                                              No (0) 
                                             Yes (1) 
 
   1.64               0.246      (0.709, 3.82)   
 
    1.52               0.273       (0.718, 3.22) 
Currently taking Antibiotics 
                                           Yes (1) 
  0.866             0.447      (0.598, 1.25) 
 
 0.833              0.291        (0.593, 1.17) 
              
                                              No (0) 
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 Table 5.1 – 4 Continued - Background Variables and HBM Perceptions (Susceptibility & Severity) 
use
 
 
Past History of Sexual Ab  
520              0.406        (0.111, 2.43) 
 
                                              No (0) 
                                             Yes (1) 
 
 
    2.18               0.322      (0.465, 10.2) 
 
 
   0.
Participates in Douching Behavior 
 
                           No (0)   2.81               0.029*     (1.11, 7.12) 
 
 1.05                0.909        (0.440, 2.52)                    
                                             Yes (1) 
 
 
  
 
  
Had Condom Problems 
                                              No (0) 
                                             Yes (1) 
 0.997              0.995      (0.420, 2.37) 
 
   1.16                0.728        (0.504, 2.66) 
  
 
  
 
  
Marijuana Use in Past Month 
es 
   2.09                0.126      (0.404, 3.48) 
   1.29                0.635      (0.204, 1.28) 
   1.48                0.439      (0.316, 2.84) 
  0.758              0.557         (0.300, 1.91) 
    1.15              0.793         (0.409, 3.22) 
  0.715              0.506         (0.266, 1.92) 
                                                None 
                                       1 – 2 times 
                                       3 – 8 times 
                                          > 9 tim
 
   (Baseline category) 
 
 
Ever Smoked Cigarettes 
 
 
                                               No (0)
                                              Yes (1)
 
    1.66               0.255      (0.692, 3.99) 
 
   1.79                0.169        (0.780, 4.12) 
Drinks Alcohol                                  
                                        Not at all 
                              Monthly or less 
                          2 to 4 times/ month 
                              4 + times/ week 
 
   (Baseline category) 
   0.623              0.212      (0.296, 1.32) 
   0.571              0.239      (0.225, 1.45) 
   dropped 
 
   
   1.70                0.166        (0.801, 3.61) 
   1.95                0.157        (0.772, 4.92) 
      (0.097, 3.02) 
   dropped 
  
  
                            2 to 3 times/ week    0.600              0.519      (0.127, 2.84)  0.542                0.484  
  
# partners in past year 
uous) 
 
   0.97             0.995       (0.420, 2.37) 
 
0.909               0.728         (0.504, 2.66)                                        (contin     
Note.  Baseline category identifies how one would compare the significance of the remaining categories for that specific variable. 
*Significant at p < 0.05 
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Table 5.1- 5  Background Variables an ie
 Regression)  
 Perceived Perceived  
g 
d HBM Perceptions (Benefits & Barr rs) 
                        (Univariate Logistic
 
 
Benefits of STD Testing Barriers to STD Testin
Variable         OR             p-value              (CI)          
     
      OR               p-value               (CI)   
Age 
                               (continuous) 
 
    0.649              0.020*       (0.451,  0 934)   
 
      1.25               0.118           (0.945, 1.65) .
Education 
                                                         <HS  
S Grad  
    >HS  
    (Baseline category) 
     1.83               0.472          (0.353, 9.49) 
     40.4               0.020*        (1.78, 917.7) 
 
      0.505             0.327          (0.129, 1.98)    
      0.281             0.200          (0.040, 1.96) 
                                                  H
                                                     
  
Attend Church 
                                                      No
                                                     Ye
 (0) 
s (1) 
8
 
77, 4.29) 
 
     2.65               0.107          (0.809, .68)        1.70              0.257          (0.6
Age at First  Intercourse                         
12  
-14  
17  
     4.46               0.111          (0.708, 28.1) 
6
*         (1.49, 29.7) 
       2.46              0.250          (0.532, 11.4) 
54, 33.4) 
                                                       <=
                                                      13
                                                      15-16  
                                                       >=
 
    (Baseline category) 
     2.88               0.217          (0.536, 15.5) 
     6.61               0.114          (0.636, 8.7)        5.65              0.056**      (0.9
 
 
       6.66              0.013
Race 
                                                      Black  
                                                     White  
er  
 
   (Baseline category) 
     0.150             0.027*        (0.28, 0.808) 
780          (0.227, 7 ) 
 
 
       0.380            0.177           (0.093, 1.55) 
       1.82              0.384           (0.472, 7.02)                                                      Oth      1.28               0. .23
Stress 
                                       Below Median  
an  6
 
284, 1.70)                                        Above Medi
 
    (Baseline category) 
     2.09               0.208          (0.663, .58)          0.696            0.427           (0.
 
Depression 
                                                        No  
s                                                         Ye
 
    0.288              0.042*        (0.086, 0.953) 
 
       1.60              0.330           (0.623, 4.08) 
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Table 5.1 – 5        Continued - Background Variables and HBM Perceptions (Benefits & Barriers) 
 
 
Social Support   
 
                                       Below Median  
                                       Above Median  
    (Baseline category) 
     0.300             0.059**      (0.0863, 1.05) 
  
       
      1.25                0.622          (0.514, 3.04) 
Health Locus of Control – Internal  
 
                                      Below Median  
                                      Above Median  
 
    (Baseline category) 
  
 
 
 
     1.63               0.331           (0.609, 4.34)       0.613              0.237          (0.272, 1.38) 
Health Locus of Control – Chance 
 
                              Below Median       (Baseline categor        
                                     Above Median  
 
 
y) 
     0.627             0.371            (0.226, 1.74)   
 
 
      0.771              0.534          (0.340, 1.75) 
Health Locus of Control –  
             Powerful Others 
 
                                     Below Median  
          Above Median                            
 
 
 
     (Baseline category) 
    1.64               0.367            (0.560, 4.80)  
 
 
  
      3.77                0.002*        (1.59, 8.90) 
       
Past STD  
                                                       No  
                                                      Yes   
 
 
    0.795             0.707             (0.240, 2.62)     1.29                0.563          (0.540, 3.10) 
 
 
  
Having symptoms 
                                                       No 
                                                      Yes  
 
     6.37              0.001**          (2.07, 19.6) 
 
      0.702              0.385          (0.316, 1.56) 
Currently taking Antibiotics 
                                               
                                                       No  
                                                      Yes  
 
 
    0.686             0.123             (0.425, 1.11)     0.913              0.611          (0.645, 1.29) 
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Table 5.1 – 5      Continued - Background erceptions (Benefits & Barriers) Variables and HBM P
 
 
Past History of Sexual Abuse 
                                                      No  
 
    2.30              0.507             (0.196, 27.1)          1.59               0.567         (0.322, 7.89)   
 
                                                     Yes  
Participates in Douching Behavior   
 
                                                      No  
                          Yes  
 
      2.11             0.239             (0.608, 7.31) 
 
       0.758             0.547         (0.307, 1.87) 
                            
Had Condom Problems 
(0.893, 8.18)        1.62               0.275         (0.679, 3.88)                                                       No  
                                                     Yes  
 
      2.70             0.078**         
      
 
Marijuana Use in Past Month 
 
                                                     None 
                                            1 – 2 times 
                                            3 – 8 times 
s 
 
 
 0.610             0.375           (0.204, 1.82) 
  0.948             0.924           (0.316, 2.84) 
        1.25              0.678        (0.440, 3.52) 
    0.423              0.101        (0.151, 1.18)                                                > 9 time
   (Baseline category) 
      1.19             0.757           (0.404, 3.48) 
   
  
 
 
 
      0.777              0.591        (0.309, 1.95) 
  
Ever Smoked Cigarettes 
(0.085, 0.841) 
 
                                                      No  
                                                     Yes  
 
    0.267             0.024*         
       
 
      0.945              0.899          (0.391, 2.28) 
Drinks Alcohol 
                                                 Not at all 
                                     Monthly or less 
 
k 
                                       4 + times/ week 
      (Baseline category) 
2.40           0.032*          (1.08, 5.33) 
0.142            (0.77, 5.81) 
dropped 
    
    1.16             0.702            (0.551, 2.42) 
 
404             0.299            (0.073, 2.23) 
     1.21             0.895            (0.071, 20.7) 
  
                                 2 to 4 times/ month
                                   2 to 3 times/ wee
 
  
2.12 
4.76 0.161           (0.536, 42.3) 
 
  
   
       1.14             0.780            (0.457, 2.84)
     0.
  
# partners in past year 
                                       (continuous) 
 
      0.833             0.024*       (0.711, 0.976)   
 
      0.958             0.410           (0.865, 1.06) 
 
Note.  Baseline category identifies how one ni
  ** Significant at p < 0.10 
would compare the significance of the remai ng categories for that specific variable. 
*Significant at p < 0.05                         
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 Table 5.1- 6  
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HBM Perceptions and their Association with Total Number of STD Tests 
Completed (Univariate Linear Regression) 
Increasing 
Number of STD Tests Completed 
N = 171 
                                                          
 
Health Belief Model 
                    Regression              Calculated              p-value                
                    Coefficient              F Statistic               
                          (CI)                                                     Perceptions 
 
Perceived Susceptibility 
       
                         0.226                       1.86                      0.174 
                  (-0.101, 0.554)                                                 
 
Perceived Severity 
 
 
                         0.240                       2.78                      0.097
                  (-0.044, 0.525) 
 
 
Perceived Benefits 
 
 
                        -0.806                       1.73                     0.190 
                  (-2.02, 0.404) 
 
Perceived Barriers 
 
 
                         0.132                       0.198                   0.657 
                  (-0.456, 0.722) 
 
Note. ing a model with the one specified perception 
            variable and the outcom
ial F s atistic tha o
terventio oup as p f the reg ion 
CI = Confidence Interval 
  Univariate regression analyses include fitt
 
p-value is derived from
in
 
n gr
e. 
 calculating a part
art o
t
analysis (significant p-values in bold) 
t controls f r the  
ress
  141
Final Model with Significant Background Variables and Perceived Severity 
ith Total Number of STD Tests Completed 
ise Multivariate Linear Regression Analysis) 
Table 5.1- 7  
                        and their Association w
                        (Stepw
 
 
 
 
 
Variables 
 
Regression Coefficient
 
 
p-value 
 
 
CI 
Age     (continuous) 
 
 
(removed) 
 
0.629 
 
Education 
                              <HS 
                HS Grad 
                      > HS 
 
(removed) 
 
. 
0.449 
0.382 
 
Race 
                    Black 
                    White 
                    Other 
 
(removed) 
 
. 
0.863 
0.168 
 
Symptoms 
 
0.922 0.059 (-0.036, 1.88) 
Currently Taking  
        Antibiotics 
0.769     <0.000 (0.352, 1.18) 
 
Ha o m Problems 
 
 
0.958 
 
 0.057 
 
(-0.030, 1.95) d C ndo
Perceiv everity 
 
(removed)       0.267  ed S
 
Note.   Significant background variables are from the analyses in Table 5.1-2. 
 
Perceived severity is the only perception variable that was significant in preliminary 
analys inal model. 
CI = Confidence Interval 
e final model were removed during the stepwise regression 
i ariate model has been controlled for the intervention variable. 
riables in this multivariate analysis are in bold. 
is and
is. 
nal multiv
icant va
 included in this f
 
 
 
Overall s
*Significant at p < 0.05 
** Significant at p < 0.10 
Nonsignificant factors in th
analys
 
This f
ignif
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